Leaders in Learning: Publications of Faculty & Staff

The University of Western Ontario


Medicine (Dept.): 1996-1997

 

ADAMS, P.C.

Adams, P.C., M.L. Campion, G. Gandon, J.Y. Legall, V. David, and A.M. Jouanolle. 1997. Clinical and genetic family studies in hemochromatosis: Microsatellite and HFE studies in five atypical families. Hepatology 26: 986-991.

Adams, P.C., Y. Deugnier, R. Moirand, and P. Brissot. 1997. The relationship between iron overload, clinical symptoms and age in 410 hemochromatosis patients. Hepatology 25: 162-166.

Assy, N., and P.C. Adams. 1997. Predictive value of the family history in the diagnosis of hereditary hemochromatosis. Digestive Diseases and Sciences 42: 1312-1315.

Boucher, E., A. Bourienne, P.C. Adams, B. Turlin, P. Brissot, and Y. Deugnier. 1997. Liver iron concentration and distribution during therapy for chronic hepatitis C. Gut 41: 115-120.

CASL Hepatitis Consensus Group, and P.C. Adams. 1997. Management of viral hepatitis: clinical and public health perspectives. Canadian Journal of Gastroenterology 11: 407-416.

Hramiak, I., D. Finegood, and P.C. Adams. 1997. Factors affecting glucose tolerance in hereditary hemochromatosis. Clinical and Investigative Medicine 20: 110-118.

Moirand, R., P.C. Adams, V. Bichelor, P. Brissot, and Y. Deugnier. 1997. Clinical features of genetic hemochromatis in women compared to men. Annals of Internal Medicine 127: 105-110.

 

AHMAD, D.

Bussieres, L.M., P.W. Pflugfelder, A.W. Taylor, D. Ahmad, C. Weernink, and W.J. Kostuk. 1997. Changes in cardiopulmonary responses to exercise after cardiac transplantation in patients enrolled in an early rehabilitation program. Canadian Respiratory Journal 4 (2): 81-87.

 

ARNOLD, J.M.O.

Arnold, J.M.O. 1997. Closing the Treatment Gap: From bench to bedside. Canadian Journal of Cardiology 13 (January) Coronary Heart Disease Prevention: The Management of Dyslipidemias, Dyslipidemia Newsletter.

Arnold, J.M.O., Z. Sasson, S. Mathias, et al. 1997. Impact of medical interventions on quality of life in cardiovascular disease: A consensus viewpoint. Canadian Journal of Cardiology 13 (3): 235-236.

The Digitalis Investigation Group, and J.M.O. Arnold. 1996. Rationale, design, implementation and baseline characteristics of patients in the DIG trial: A large simple, longterm trial to evaluate the effect of digitalis on
mortality in heart failure. Controlled Clinical Trials 17: 77-97.

The Digitalis Investigation Group, J.M.O. Arnold, and M.E. Weingert. 1997. The effect of digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine 336 (8): 525-533.

Driscoll, M.D., J.M.O. Arnold, G.E. Marchiori, L.A. Harker, and M.H. Sherebrin. 1997. Determination of appropriate recording force for noninvasive measurement of arterial pressure pulses. Clinical Science 92 (6): 559-566.

Lui, A.S.O., and J.M.O. Arnold. 1996. Response of large superficial dorsal hand veins to locally infused nitroglycerine in young, normal subjects. Canadian Journal of Physiology 74: 1034-1038.

Pfeffer, M.A., S.C. Greaves, J.M.O. Arnold, R.G. Glynn, F.S. LaMotte, R. Lee, F.J. Menapace Jr., E. Rapaport, P.M. Ridker, J.-L. Rouleau, S. Solomon, and C.H. Hennekens. 1997. Early versus delayed angiotensinconverting enzyme inhibition therapy in acute myocardial infarction: The healing and early afterload reducing therapy trial. Circulation 95 (12): 2643-2651.

Rau, S.E., J.R. Bend, J.M.O. Arnold, L.T. Tran, J.D. Spence, and D.G. Bailey. 1997. Grapefruit juice - terfenadine single-dose interaction: Magnitude, mechanism and relevance. Clinical Pharmacology and Therapeutics 61 (4): 401-409.

Vantrimpont, P., J.L. Rouleau, C.-C. Wun, A. Ciampi, M. Klein, B. Sussex, J.M.O. Arnold, et al. 1997. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study. Journal of the American College of Cardiology 29 (2): 229-236.

Vaughan, D.E., J.L. Rouleau, P.M. Ridker, J.M.O. Arnold, et al. 1997. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation 96 (2): 442-447.

 

BAILEY, D.G.

Lown, K.S., D.G. Bailey, R.J. Fontana, S.K. Janardan, C.S. Adair, L.A. Fortlage, M.B. Brown, W. Guo, and P.B. Watkins. 1997. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. Journal of Clinical Investigation 99: 2545-2553.

Rau, S.E., J.R. Bend, J.M.O. Arnold, L.T. Tran, J.D. Spence, and D.G. Bailey. 1997. Grapefruit juice - terfenadine single-dose interaction: Magnitude, mechanism and relevance. Clinical Pharmacology and Therapeutics 61 (4): 401-409.

 

BARTLETT, A.

Ito, Y., R. Veldhuizen, L.J. Yao, L. McCaig, A. Bartlett, and J.F. Lewis. 1997. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. American Journal of Respiratory and Critical Care Medicine 155 (2): 493-499.

 

BEHME, M.T.

Atkison, P.R., P. Zucker, I. Hramiak, T.L. Paul, J. Dupre, M.T. Behme, D.S.W. Scharp, P.E. Lacy, B.J. Olack, and C.R. Stiller. 1996. Continued insulin dependence despite normal range insulin sensitivity and insuline connecting peptide levels in a kidney/islet transplant patient. Diabetes Care 19 (3): 236-240.

Dupre, J., M.T. Behme, I. Hramiak, and T.J. McDonald. 1997. Subcutaneous glucagon-like peptide I combined with insuline normalizes post cibal glycaemic excursions in IDDM. Diabetes Care 20: 381-384.

Guan, J., P.F. Zucker, M.T. Behme, and J. Dupre. 1997. Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes 46: 372-378.

 

BELL, D.A.

Mahmoudi, M., J.Y. Edwards, D.A. Bell, and E. Cairns. 1997. V region gene analysis of human IgM hybridoma monoclonal anti-Sm antibodies. Lupus 6: 578-590.

 

BELLAMY, N.

Bellamy, N. 1997. Etodolac in the management of pain: A clinical review of a multi-purpose analgesic. Inflammopharmacology 5: 139-152.

Bellamy, N. 1996. Measuring beneficial and adverse events in osteoarthritis clinical trials. Inflammopharmacology 4: 141-148.

Bellamy, N. 1997. Measuring beneficial and adverse events in osteoarthritis clinical trials. Side Effects of Anti-inflammatory Drugs IV. K.D. Rainsford. London: Kluwer Academic Publishers. 35-42.

Bellamy, N. 1997. Osteoarthritis clinical trials: Candidate variables and clinimetric properties. Journal of Rheumatology 24: 768-778.

Bellamy, N. 1996. WOMAC Osteoarthritis Index: A User's Guide. 2nd ed.

Bellamy, N., and L.A. Bradley. 1996. Workshop on chronic pain, pain control and patient outcomes in rheumatoid arthritis and osteoarthritis. Arthritis and Rheumatism 39: 357-362.

Bellamy, N., and W.W. Buchanan. 1996. Clinical evaluation in the rheumatic diseases. Arthritis and Allied Conditions. 13th ed. W.J. Koopman. Philadelphia: Lee and Febiger. 47-79.

Bellamy, N., R. Buchbinder, S.S. Hall, P. Lowthian, M.R. Patrick, P.F.J. Ryan, A. Stockman, G. Grant, S. Green, and J. Campbell. 1997. Effect of a standardized videotape on observer dependent outcome measures in fibromyalgia. Inflammopharmacology 5: 3-14.

Bellamy, N., J. Kirwan, M. Boers, P. Brooks, V. Strand, P. Tugwell, R. Altman, K. Brandt, M. Dougados, and M. Lequesne. 1997. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis: Consensus development in OMERACT III. Journal of Rheumatology 24: 799-802.

Bellamy, N., K.D. Muirden, A. Bendrups, K. Boyden, G. McColl, H. Moran, A. Stockman, M.M.T.R. Tellus, and J. Campbell. 1997. Effect of a standardized videotape on observer dependent outcome measures in rheumatoid arthritis. Inflammopharmacology 5: 15-26.

Bellamy, N., K.D. Muirden, K. Boyden, G. McColl, H. Moran, A. Stockman, M.M. Tellus, I. Wicks, and J. Campbell. 1997. Effect of a standardized videotape on observer dependent outcome measures in ankylosing spondylitis. Inflammopharmacology 5: 39-50.

Buchanan, W.W., K. Al-Jarallah, and N. Bellamy. 1996. Outcome measures in clinical trials of anti-rheumatic drugs. Advances in Anti-Rheumatic Therapy. K.D. Rainsford. Boca Raton, Florida: CRS Press Inc. 11-23.

Buchanan, W.W., and N. Bellamy. 1997. The placebo response: Clinical efficacy and toxicity. Side Effects of Anti-Inflammatory Drugs IV. K.D. Rainsford. London: Kluwer Academic Publishers. 11-23.

 

BEND, J.R.

Rau, S.E., J.R. Bend, J.M.O. Arnold, L.T. Tran, J.D. Spence, and D.G. Bailey. 1997. Grapefruit juice - terfenadine single-dose interaction: Magnitude, mechanism and relevance. Clinical Pharmacology and Therapeutics 61 (4): 401-409.

 

BLAKE, P.G.

Blake, P.G. 1996. Adequacy of peritoneal dialysis. Current Opinions in Nephrology and Hypertension 5: 492-496.

Blake, P.G. 1997. Noncompliance in peritoneal dialysis patients. Peritoneal Dialysis International 17 (July): 330-332.

Blake, P.G. 1997. What is the problem with high transporters? Peritoneal Dialysis International 17 (July): 317-320.

Blake, P.G., J. Burkart, D. Churchill, et al. 1996. Ad Hoc Committee on Peritoneal Dialysis Adequacy. Peritoneal Dialysis International 16: 448-457.

Jones, M., R. Kalil, P.G. Blake, L. Martis, and D.G. Oreopoulos. 1997. Modification of an amino acid solution for peritoneal dialysis to reduce the risk of acidemia. Peritoneal Dialysis International 17: 66-71.

Lindsay, R.M., P.G. Blake, P. Malek, G. Posen, B. Martin, and E. Bradfield. 1997. Haemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. American Journal Kidney Diseases 30 (4): 475-482.

 

BORRIE, M.J.

Hartman, D., M.J. Borrie, E. Davison, and P. Stolee. 1997. Use of Goal Attainment Scaling in a Dementia Special Care Unit. American Journal of Alzheimer's Disease (May/June): 111-116.

 

BORRON, P.

Borron, P., R. Veldhuizen, L.J. Fraher, F. Possmayer, A.N. Caveney, J.F. Lewis, K. Inchley, and R.G. McFadden. 1996. Bovine surfactant associated protein-A inhibits phytohaemagglutonin stimulated human lymphocytes, proliferation and IL-2 production. American Journal of Respiratory Cell and Molecular Biology 15: 115-121.

 

BOUGHNER, D.R.

Canham, P.B., H.M. Finlay, and D.R. Boughner. 1997. Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels. Cardiovascular Research 57: 557-567.

Duncan, A.C., D.R. Boughner, and I. Vesely. 1996. Dynamic glutaraldehyde fixation of a porcine aortic valve xenograft: I Effect of fixation conditions on the final tissue viscoelastic properties. Biomaterials 17 (19): 1849-1856.

Duncan, A.C., D.R. Boughner, and I. Vesely. 1997. Viscoelasticity of dynamically fixed bioprosthetic valves: II Effect of glutaraldehyde concentration. Journal of Thoracic and Cardiovascular Surgery 113 (2): 302-310.

Duncan, A., and D.R. Boughner. 1997. Concentration of glutaraldehyde in fixation of bioprosthetic valves. Thoracic and Cardiovascular Surgeon 113: 103-110.

Yu, P., D.R. Boughner, W.J. Sibbald, J. Keys, J. Dunmore, and C.M. Martin. 1997. Myocardial collagen changes and edema in rats with hyperdynamic sepsis. Critical Care Medicine 25: 657-662.

 

BRIEN, W.F.

Delorme, M.A., B. O'Keefe, M. Schaus, K. Mizzi, W.F. Brien, and M.J. Inwood. 1996. Investigation of a prolonged aPTT: a modified approach. Laboratory Hematology 2: 106-110.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1997. A point score system for predicting the likelihood of blood transfusion after hip r knee arthroplasty. Transfusion 37: 463-467.

Levine, M., M. Gent, J. Hirsh, J. Leclerc, D. Anderson, J. Weitz, J. Ginsberg, A.G. Turpie, C. Demers, M.J. Kovacs, W. Geerts, J. Kassis, L. Desjardins, J. Cusson, M.K. Cruickshank, P. Powers, W.F. Brien, S. Haley, and A. Willan. 1996. A comparison of low-molecular-weight heparin administered primarily at home with unfractioned heparin administered in the hospital for proximal deep-vein thrombosis. New England Journal of Medicine 334: 677-681.

 

BRYMER, C.D.

Brymer, C.D., and F. Ellett. 1997. America's Best Geriatric Hospitals? Journal of the American Geriatrics Society 45 (4): 531.

Wells, J., L. Diachun, C. Cook, and C.D. Brymer. 1996. Internal Medicine Residents' Attitudes Toward and Knowledge of Geriatric Medicine. Annals of the Royal College of Physicians and Surgeons of Canada 29 (8): 468-472.

 

CAIRNS, E.

Mahmoudi, M., J.Y. Edwards, D.A. Bell, and E. Cairns. 1997. V region gene analysis of human IgM hybridoma monoclonal anti-Sm antibodies. Lupus 6: 578-590.

Sawchuk, D.J., M. Mahmoudi, E. Cairns, and N.R.S. Sinclair . 1996. Nonsynonymous mutations in a Fc-receptor structural gene in NZB mice. Immunogenetics 43: 112-114.

 

CARRUTHERS, S.G.

Armstrong, P.W., J.A. Cairns, S.G. Carruthers, et al. 1997. Canadian academic departments of medicine amidst health care reform. Annals of Royal Canadian College of Physicians & Surgeons of Canada 30: 279-282.

Carruthers, S.G. 1997. Hypertension, Cardiovascular Disorders (Chapter 22). Therapeutic Choices. 2nd ed. J. Gray. Ottawa, ON: Canadian Pharmaceutical Association.

Carruthers, S.G. 1997. The place of angiotensin II antagonists in relation to the Canadian Hypertension Society Guidelines. Angiotensin II Receptor Blockade: Physiological and Clinical Implications. N.S. Dhalla, P. Zahradka, I.M.C. Dixon, and R.E. Beamish. Boston, MA: R.E. Beamish Kluwer Academic Publishers.

 

CAVENEY, A.N.

Borron, P., R. Veldhuizen, L.J. Fraher, F. Possmayer, A.N. Caveney, J.F. Lewis, K. Inchley, and R.G. McFadden. 1996. Bovine surfactant associated protein-A inhibits phytohaemagglutonin stimulated human lymphocytes, proliferation and IL-2 production. American Journal of Respiratory Cell and Molecular Biology 15: 115-121.

 

CHIN-YEE, I.H.

Chin-Yee, I.H., S. Alshammari, L. Anderson, M. Kadri, and M. Keeney. 1996. Comparison of two methods to detect P-glycoprotein in patients with chronic lymphocytic leukemia. Clinical and Laboratory Haematology 18: 99-104.

Chin-Yee, I.H., L. Anderson, and M. Keeney. (1997). Staging bone marrows for non-Hodgkin's lymphoma (NHL): A comparison of bone marrow biopsy versus flow cytometry to detect marrow involvement. Laboratory Hematology 2 (1): 9-11.

Chin-Yee, I.H., K. Bezchlibnyk-Butler, and L. Wong. 1996. Cytokines in Clozapine-Induced Agranulocytosis. Canadian Journal of Psychiatry 41 (June): 280-284.

Chin-Yee, I.H., S. Halasi, and A. Hassan. 1996. Successful Treatment of Perianal ulcers in a patient with Felty's syndrome using granulocyte colony stimulating factor (G-CSF). Journal of Clinical Rhematology 2 (5).

Sielenkemper, A.W., I.H. Chin-Yee, C.M. Martin, and W.J. Sibbald. 1996. Diapirin cross-linked hemoglobin improves system oxygen uptake in oxygen supply-dependent septic rats. American Journal of Respiratory and Critical Care Medicine 154 (3).

 

CHORAZYCZEWSKI, J.

Feldman, R.D., and J. Chorazyczewski. 1997. G-protein function is reduced in hypertension. Hypertension 29: 422-427.

 

CHOW, L.H.

Chow, L.H., S. Huh, J. Jiang, R. Zhong, and J.G. Pickering . 1996. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation 94 (12): 3079-3082.

Guiraudon, G., C. Guiraudon, L.H. Chow, R. Yee, W.J. Kostuk, and G.J. Klein. 1996. Latissimus dorsi cardiomyoplasty combined with ICD implant. Les journees de la Pitie: Transplantation cardiaque et pulmonaire, cardiomyoplastie, assistance circulatoire. C. Cabrol, I. Gandjbakhch, and A. Pavie. Montpellier, France: R & J Editions Medicales and Sauramps. 167-170.

Pickering, J.G., C.M. Ford, and L.H. Chow. 1996. Evidence for rapid accumulation and persistently disordered architecture of fibrillar collagen in human coronary restenosis lesions. American Journal of Cardiology 78: 633-637.

Pickering, J.G., C.M. Ford, B. Tang, and L.H. Chow. 1997. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells: evidence for repressed collagen production and activated degradative capacity. Arteriosclerosis, Thrombosis, and Vascular Biology 17 (3): 475-482.

Pickering, J.G., S. Uniyal, C.M. Ford, T. Chau, M.A. Laurin, L.H. Chow, C.G. Ellis, J. Fish, and B.M.C. Chan. 1997. Fibroblast growth factor-2 potentiates vascular smooth muscle cell migration to platelet-derived growth factor: Upregulation of integrin and disassembly of actin filaments. Circulation Research 80 (5): 627-637.

 

CLARK, W.F.

Clark, W.F., and K.K. Carroll. Eating for Health. Western Gazette (Summer): 18-20.

 

CRUICKSHANK, M.K.

Levine, M., M. Gent, J. Hirsh, J. Leclerc, D. Anderson, J. Weitz, J. Ginsberg, A.G. Turpie, C. Demers, M.J. Kovacs, W. Geerts, J. Kassis, L. Desjardins, J. Cusson, M.K. Cruickshank, P. Powers, W.F. Brien, S. Haley, and A. Willan. 1996. A comparison of low-molecular-weight heparin administered primarily at home with unfractioned heparin administered in the hospital for proximal deep-vein thrombosis. New England Journal of Medicine 334: 677-681.

 

DELORME, M.A.

Delorme, M.A. 1997. Alternatives to plasma-derived coagulation factors. Canadian Society for Transfusion Medicine Bulletin 9: 18-27.

Delorme, M.A., B. O'Keefe, M. Schaus, K. Mizzi, W.F. Brien, and M.J. Inwood. 1996. Investigation of a prolonged aPTT: a modified approach. Laboratory Hematology 2: 106-110.

 

DOIG, G.S.

Cooper, A.B., G.S. Doig, and W.J. Sibbald. 1996. Pulmonary artery catheters in the critically ill. Critical Care Clinics: Monitoring Cardiac Function and Tissue Perfusion 12 (4): 777-794.

Elit, L.M., M.N. Levine, A. Gafni, T.J. Whelan, G.S. Doig, D.L. Streiner, and B. Rosen. 1996. Patients' preferences for therapy in advanced epithelial ovarian cancer: Development, testing and application of a bedside decision instrument. Gynecologic Oncology 62: 329-335.

Engel, C.J., S.T. Bennett, A.F. Chambers, G.S. Doig, N. Kerkvliet, and F.P. O'Malley. 1996. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. American Journal of Surgical Pathology 20 (10): 1260-1265.

Fitzgerald, R.D., C.M. Martin, G.E. Dietz, G.S. Doig, R.F. Potter, and W.J. Sibbald. 1997. Transfusing RBCs stored in CPDA-1 for 28 days fails to improve tissue oxygenation in rats. Critical Care Medicine 25: 726-732.

Foster, D.F., and G.S. Doig. 1997. Clinical Trials for the Evaluation of Sepsis Therapies. 1997 Yearbook of Intensive Care and Emergency Medicine. J.L. Vincent. Berlin: Springer-Verlag. 161-167.

Hachinski, V.C., C. Graffagnino, M. Beaudry, G. Bernier, C. Buck, A. Donner, J.D. Spence, G.S. Doig, and B.M. Wolfe. 1996. Hyperlipidemia is a significant risk factor for stroke. Archives of Neurology 53: 303-308.

Keenan, S.P., G.S. Doig, C.M. Martin, K.J. Inman, and W.J. Sibbald. 1997. Assessing the efficiency of the admission process to a critical care unit: Does the literature allow the use of benchmarking? Intensive Care Medicine 23: 574-580.

Lane, P.L., G.S. Doig, A. Mikrogianakis, and T. Stefanitis . 1996. An evaluation of Ontario trauma outcomes and the development of regional norms for TRISS analysis. Journal of Trauma 41 (4): 731-734.

Lane, P.L., G.S. Doig, T.C. Stewart, A. Mikrogianakis, and T. Stefanits. 1997. Trauma outcome analysis and the development of regional norms. Accident Analysis and Prevention 29 (1): 53-56.

Ng, S.W., R. Esmail, W.J. Sibbald, and G.S. Doig. 1996. Potential savings involved in the purchase of low-cost, high-volume medical commodities as established from a community hospital survey. Healthcare Management Forum 9: 24-30.

O'Malley, F.P., Z. Saad, N. Kerkvliet, G.S. Doig, L. Stitt, P. Ainsworth, H. Hundal, A.F. Chambers, D.I. Turnbull, and V. Bramwell. 1996. The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer. Human Pathology 27 (9): 955-963.

 

DUPRE, J.

Atkison, P.R., P. Zucker, I. Hramiak, T.L. Paul, J. Dupre, M.T. Behme, D.S.W. Scharp, P.E. Lacy, B.J. Olack, and C.R. Stiller. 1996. Continued insulin dependence despite normal range insulin sensitivity and insuline connecting peptide levels in a kidney/islet transplant patient. Diabetes Care 19 (3): 236-240.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 45: 1289-1298.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1997. Clustering of long-term complications in families with diabetes in The Diabetes Control and Complications Trial. Diabetes 46: 1829-1839.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1997. Hypoglycaemia in the DCCT. Diabetes 46: 271-286.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. Lifetime benefits and costs of intensive therapy as practised in the Diabetes Control and Complication Trial. JAMA 276: 1409-1415.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. Pregnancy outcomes in the DCCT. American Journal of Obstetrics and Gynecology 174: 1343-1353.

Dupre, J. 1997. The Nobel Prize awards for research in diabetes. Diamet News 45: 1-4.

Dupre, J., M.T. Behme, I. Hramiak, and T.J. McDonald. 1997. Subcutaneous glucagon-like peptide I combined with insuline normalizes post cibal glycaemic excursions in IDDM. Diabetes Care 20: 381-384.

Dupre, J., J.L. Mahon, and C.R. Stiller. 1997. Prevention of development of progression of B-cell damage in insulin-dependent diabetes mellitus. Textbook of Diabetes, Volume 82.1. J. Pickup, and G. Williams. Oxford: Blackwell Scientific Publications. 82.11.

Guan, J., P.F. Zucker, M.T. Behme, and J. Dupre. 1997. Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes 46: 372-378.

Mahon, J.L., and J. Dupre. 1997. The limitations of clinical trials of prevention for insulin dependent diabetes mellitus. Diabetes Care 20: 1027-1033.

 

EDMONDS, M.W.

Edmonds, M.W. 1997. Computer Assisted Management of Diabetes Mellitus. COACH Conference 22 Proceedings. 144-151.

Edmonds, M.W. 1997. Dyslipidemia in Diabetes Mellitus. The Canadian Journal of CME 9: 63-71.

Kraus, R.P., E. Phoenix, M.W. Edmonds, I.R. Nicholson, P.C. Chandarana, and S. Tokmakejian. 1997. Exaggerated TSH responses to TRH in depressed patients with 'normal' baseline TSH. Journal of Clinical Psychiatry 58: 266-270.

 

FEAGAN, B.G.

Archambault, A., and B.G. Feagan. 1997. The basis for new knowledge: Research and clinical trials. First Principles of Gastroenterology. 2nd ed. A.B.R. Thomson.

Atkinson, K.A., J.W.D. McDonald, B. Lamba, and B.G. Feagan . 1997. Intravenous cyclosporine for severe attacks of ulcerative colitis: A survey of Canadian gastroenterologists. Canadian Journal of Gastroenterology 11 (7): 583-587.

Feagan, B.G. 1997. Does Immunosuppressive Drug Therapy Improve Patients' Quality of Life? New Approaches in the Management of Inflammatory Bowel Diseases: From Concept to Clinic. Projects in Knowledge.

Feagan, B.G. 1997. Immunosuppressants: Which and when? Inflammatory Bowel Diseases, From Bench to Bedside. Proceedings of the Falk Symposium.

Feagan, B.G. 1997. Inflammatory Bowel Disease Therapeutic Choices. Canadian Pharmaceutical Association.

Feagan, B.G. 1997. Methotrexate therapy for chronic sarcoidosis: Is the therapeutic index acceptable? Journal of Pediatrics 130: 3-4.

Feagan, B.G., and J.W.D. McDonald. 1997. Cyclosporine in Crohn's disease. Lancet 349: 1328.

Feagan, B.G., and J.W.D. McDonald. 1997. Medical therapy for inflammatory bowel disease. Current Opinion in Gastroenterology 13: 307-311.

Irvine, E.J., B.G. Feagan, and C. Wong. 1996. Does self-administration of a Quality of Life Index for inflammatory bowel disease change the results? Journal of Clinical Epidemiology 49: 1177-1185.

Irvine, E.J., Q. Zhou, A.K. Thompson, A. Archambault, B.G. Feagan, et al. 1996. The Short Inflammatory Bowel Disease Questionnaire: A Quality of Life instrument for community physicians managing inflammatory bowel disease. American Journal of Gastroenterology 91 (8): 1571-1578.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. Patient directed hypertention management. American Journal of Hypertension 10: 58-67.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. American Journal of Hypertension 10: 58-67.

 

FELDMAN, R.D.

Feldman, R.D. 1997. Angiotensin II receptor blockade: A new target for clinical intervention in hypertension. Canadian Journal of Diagnosis.

Feldman, R.D., and J. Chorazyczewski. 1997. G-protein function is reduced in hypertension. Hypertension 29: 422-427.

Feldman, R.D., A.G. Logan, and N.D. Schmidt. 1996. Dietary salt aggravates vascular insulin resistance. Clinical Pharmacology and Therapeutics 60: 444-451.

Gros, R., J.L. Benovic, C.M. Tan, and R.D. Feldman. 1997. G-protein coupled receptor-kinase activity is increased in hypertension. Journal of Clinical Investigation 99: 2087-2093.

Steele, A., M. Gowrishankar, S. Abrahmson, D. Mazer, R.D. Feldman, and M.L. Halperin. 1997. Post-operative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Annals of Internal Medicine 126: 20-25.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. Patient directed hypertention management. American Journal of Hypertension 10: 58-67.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. American Journal of Hypertension 10: 58-67.

 

FERGUSON, K. A.

Ferguson, K.A., T. Ono, A.A. Lowe, S.A. Al-Majed, and J.A. Fleetham. 1997. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnea. Thorax 52 (4): 362-368.

 

FINNIE, K.J.C.

Cairns, J.A., J. Gill, B. Morton, R. Roberts, M. Gent, J. Hirsh, D. Holder, K.J.C. Finnie, J.F. Marquis, Naqvi. S., and E. Cohen. 1996. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. Circulation 94 (7): 1553-1560.

CAPRIE Steering Committee, and K.J.C. Finnie. 1996. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329-1339.

Finnie, K.J.C., and L.J. Melendez. 1997. Chest pain and left bundle branch block. Canadina Journal of Diagnosis 14 (5): 31-32.

Finnie, K.J.C., and L.J. Melendez. 1996. The falling sickness? Canadian Journal of Diagnosis 13 (9): 27-28.

Finnie, K.J.C., and L.J. Melendez. 1996. A light problem. Canadian Journal of Diagnosis 13 (8): 29-32.

Finnie, K.J.C., and L.J. Melendez. 1997. A little excitement. Canadian Journal of Diagnosis 14 (1): 33-35.

Finnie, K.J.C., and L.J. Melendez. 1996. A paroxysmal tachycardia. Canadian Journal of Diagnosis 13 (11): 31-32.

Finnie, K.J.C., and L.J. Melendez. 1997. PVCs? Canadian Journal of Diagnosis 14 (3): 35-37.

Hurwitz, G.A., A.C. MacDonald, M.E. Weingert, R.C. Hessian, K.J.C. Finnie, G. St. Clement, and J.E. Powe. 1996. Myocardial uptake and washout kinetics of T1-201 with the VEX (vasodilator plus exercise) test: Contribution of stress mode components and coronary stenosis severity. Canadian Journal of Cardiology 12 (7): 648-656.

Melendez, L.J., and K.J.C. Finnie. 1996. Another type? Canadian Journal of Diagnosis 13 (12): 35-38.

Melendez, L.J., and K.J.C. Finnie. 1997. Please don't follow me. Canadian Journal of Diagnosis 14 (6): 31-32.

Melendez, L.J., and K.J.C. Finnie. 1997. Postoperative dysrhythmia. Canadian Journal of Diagnosis 14 (4): 31-32.

Melendez, L.J., and K.J.C. Finnie. 1996. Sudden severe dyspnea. Canadian Journal of Diagnosis 13 (7): 29-32.

Melendez, L.J., and K.J.C. Finnie. 1996. Through the narrow gate. Canadian Journal of Diagnosis 13 (10): 31-32.

Melendez, L.J., and K.J.C. Finnie. 1997. What, where and how? Canadian Journal of Diagnosis 14 (2): 33-34.

 

FRAHER, L.J.

Borron, P., R. Veldhuizen, L.J. Fraher, F. Possmayer, A.N. Caveney, J.F. Lewis, K. Inchley, and R.G. McFadden. 1996. Bovine surfactant associated protein-A inhibits phytohaemagglutonin stimulated human lymphocytes, proliferation and IL-2 production. American Journal of Respiratory Cell and Molecular Biology 15: 115-121.

Gagnon, R., J. Murotsuki, J.R.G. Challis, L.J. Fraher, and B.S. Richardson. 1997. Fetal sheep endocrine responses to sustained hypoexemic stress after chronic fetal placental embolization. American Journal of Physiology: Endocrinology and Metabolism 272: E817-E823.

Hodsman, A.B., L.J. Fraher, R. Ostbye, J.D. Adachi, D.H. Taves, and D. Drost. 1997. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in post-menopausal women with osteoporosis. Journal of Clinical Endocrinology 82: 620-628.

Hodsman, A.B., L.J. Fraher, and P.H. Watson. 1997. Parathyroid Hormone: The Clinical Experience and Prospects. Anabolic Treatments for Osteoporosis. J.E. Whitfield, and P. Morley. Boca Raton, FL: CRC Press. 83-108.

Murotsuki, J., J.R.G. Challis, V.K.M. Han, L.J. Fraher, and R. Gagnon. 1997. Chronic fetal placental embolization and hypoxemia cause hypertension and myocardial hypertrophy in fetal sheep. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 272: R201-R207.

Toogood, J.H., F.A. White, J.C. Baskerville, L.J. Fraher, and B. Jennings. 1997. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbohaler dry powder inhaler. Journal of Allergy and Clinical Immunology 99: 186-193.

 

FREEMAN, D.J.

Freeman, D.J., M. Li, and L.K. Oyewumi. 1996. Solid-phase extraction and HPLC analysis of clozapine and norclozapine in human plasma. Therapeutic Drug Monitoring 18: 688-692.

Freeman, D.J., and K. Oyewumi. 1997. Will routine therapeutic drug Monitoring have a place in clozapine therapy? Clinical Pharmacokinetics 32 (2): 93-100.

Ozcay, N., J. Fryer, D. Grant, D.J. Freeman, B. Garcia, and B. Zhong. 1997. Budesonide, A Locally Acting Steroid Prevents Small Bowel Allograft Rejection Without Systemic Side Effects. Transplantation 63: 1220-1225.

 

GHENT, C.

Ghent, C. 1996. Overall evaluation: Screening and assessment of risk factors. Liver Transplantation and Surgery 2: 2-8.

Verran, D., S. Asfar, C. Ghent, D. Grant, and W. Wall. 1997. Biliary complications in 502 consecutive orthotopic liver transplants. Liver Transplantation and Surgery 3: 365-373.

 

GILBERT, K.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1997. A point score system to predict the likelihood of blood transfusion following hip or knee arthroplasty. Transfusion 37: 463-467.

 

GREGSON, D.B.

DaSilva, O., D.B. Gregson, and O. Hammerberg. 1997. The role of U urealyticum and C trachomatis in the development of bronchopulmonary dysplasia in the very low birth weight infant. Pediatric Infectious Disease Journal 16: 364-369.

 

GUAN, J.

Guan, J., P.F. Zucker, M.T. Behme, and J. Dupre. 1997. Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts. Diabetes 46: 372-378.

 

GUENTHER, L.C.

Guenther, L.C. 1997. New medication available for plaque psoriasis. Psoriasis Society of Canada's Newsletter (Spring)

Guenther, L.C. (Reviewer/Editor). (1997). Tazorac Brochure. Canadian Psoriasis Foundation.

Kim, H.L., Y. Bo-Abbas, and L.C. Guenther. 1996. Cold-induced skin disorders. Journal of Cutaneous Medicine and Surgery 1 (2): 119-130.

 

HAMMERBERG, O.

DaSilva, O., D.B. Gregson, and O. Hammerberg. 1997. The role of U urealyticum and C trachomatis in the development of bronchopulmonary dysplasia in the very low birth weight infant. Pediatric Infectious Disease Journal 16: 364-369.

 

HARTH, M.

Sampalis, J.S., T.A. Medsger, J.F. Fries, C. Yeadon, J.-L. Senecal, D. Myhal, M. Harth, A. Gutowski, B.F. Carette, A.J. Partridge, and J.M. Esdaile. 1996. Risk factors for adult Still's disease. Journal of Rheumatology 23: 2049-2054.

Teasell, R.W., and M. Harth. 1996. Returning patients with chronic low back pain to work - revolution or fad? Spine 21: 844-847.

 

HEGELE, R.A.

Hegele, R.A. 1997. Candidate genes, small effects and the prediction of atherosclerosis. Critical Reviews In Clinical Laboratory Sciences 34: 343-367.

Hegele, R.A. 1997. The genetic basis of atherosclerosis. International Journal of Clinical and Laboratory Research 27: 2-13.

Hegele, R.A. 1997. Is it time to measure (Lp(a) as part of coronary heart disease risk assessment? Clinical Biochemistry 30: 443-445.

Hegele, R.A. 1996. Pathogenesis of atherosclerosis. Clinica Chimica Acta 246: 21-38.

Hegele, R.A. 1996. The role of lipids in cardiovascular disease: Lessons from rare mutations and special populations. Clinical and Investigative Medicine 19: 161-170.

Hegele, R.A., J.H. Brunt, and P.W. Connelly. 1996. Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate. Hypertension 27: 308-312.

Hegele, R.A., P.W. Connelly, A.J.G. Hanley, F. Sun, S.B. Harris, and B. Zinman. 1997. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arteriosclerosis, Thrombosis, and Vascular Biology 17: 1060-1066.

Hegele, R.A., P.W. Connelly, S.W. Scherer, A.J.G. Hanley, S.B. Harris, L.-C. Tsui, and B. Zinman. 1997. Paraoxonase-2 G148 variant in a 12 year old aboriginal Canadian female with non-insulin dependent diabetes. Lancet 350: 785.

Hegele, R.A., S. Gandhi, J.H. Brunt, and P.W. Connelly. 1996. Restriction isotyping of the premature termination codon in exon 9 of lipoprotein lipase in Alberta Hutterites. Clinical Biochemistry 29: 63-66.

Hegele, R.A., S.B. Harris, A.J.G. Hanley, S. Sadikian, P.W. Connelly, and B. Zinman. 1996. Genetic variation of intestinal fatty acid binding protein associated with variation in body mass in aboriginal Canadians. Journal of Clinical Endocrinology and Metabolism 81: 4334-4337.

Hegele, R.A., S.B. Harris, A.J.G. Hanley, F. Sun, P.W. Connelly, and B. Zinman. 1997. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 29: 1073-1077.

Hegele, R.A., M. Jugenberg, P.W. Connelly, and D.J.A. Jenkins. 1997. Evidence for gene-diet interaction in the response of blood pressure to dietary fibre. Nutrition Research 17: 1229-1238.

Hegele, R.A., C. Tully, T.K. Young, and P.W. Connelly. 1997. V677 mutation of methylenetetrahydrofolate reductase and cardiovascular disease in Canadian Inuit. Lancet 349: 1221-1222.

Hegele, R.A., T.K. Young, and P.W. Connelly. 1997. Are Canadian Inuit at increased risk for coronary heart disease? Journal of Molecular Medicine 74: 364-370.

Hegele, R.A., B. Zinman, A.J.G. Hanley, S.H. Harris, and P.W. Connelly. 1997. A common mtDNA polymorphism associated with variation in plasma triglyceride concentration. American Journal of Human Genetics 60: 1552-1555.

Hsia, S.H., P.W. Connelly, and R.A. Hegele. 1997. Hyperlipidemia and pancreatitis during pregnancy. Annals of Internal Medicine 126: 88-89.

Hsia, S., P.W. Connelly, and R.A. Hegele. 1996. Genetic diagnosis of familial hypercholesterolemia in affected relatives using pedigree tracking. Clinical Biochemistry 29: 371-377.

Mackness, M.I., B. Mackness, P.N. Durrington, P.W. Connelly, and R.A. Hegele. 1996. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Current Opinion in Lipidology 7: 69-76.

Ng, D.S., P.W. O'Connor, C.B. Mortimer, L.A. Leiter, P.W. Connelly, and R.A. Hegele. 1996. Retinopathy and neuropathy associated with complete apolipoprotein A-1 deficiency. American Journal of Medical Science 312: 30-33.

Whitman, S.C., D.B. Miller, B.M. Wolfe, R.A. Hegele, and M.W. Huff. 1997. Uptake of type III hypertriglyceridemic VLDL by macophages is enhanced by oxidation, especially after remnant formation. Arteriosclerosis, Thrombosis, and Vascular Biology 17: 1707-1715.

Wolever, T.M.S., R.A. Hegele, P.W. Connelly, T.P.P. Ransom, J.A. Story, E.J. Furumoto, and D.J.A. Jenkins. 1997. Long-term effects of soluble fiber foods on postprandial fat metabolism in dyslipidemic subjects with apoE3 and apoE4 genotypes. American Journal of Clinical Nutrition 66: 584-590.

 

HILL, D.J.

Arany, E., P. Zabel, and D.J. Hill. 1996. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach. Growth Regulation 6: 32-41.

Gonzalez, A.M., D.J. Hill, A. Logan, P. Maher, and A. Baird. 1996. Complimentary distribution of fibroblast growth factor-2 (FGF-2) and FGF receptor-1 FGFR1) messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatric Research 39: 375-385.

Hill, D.J. 1997. Extracellular matrix in islet growth and function. Cellular inter-relationships in the pancreas - Implications for islet transplantation. L. Rosenberg, and W.P. Duguid. Austin: Landes Bioscience. 87-97.

Hill, D.J. 1996. Growth factors in epiphyseal chrondogenesis. Society for Experimental Biology Seminar Series, Volume 60. J. Pell, and P. Loughna. Cambridge: Cambridge University Press. 35-47.

Hill, D.J. 1996. Insulin secretion: Lessons from tissue culture. Diabetes Reviews : 390-402.

Hill, D.J., A. Flyvbjerg, E. Arany, F.F. Lauszus, and J.G. Klebe. 1997. Increased levels of serum fibroblast growth factor-2 (FGF-2) in diabetic pregnant women with retinopathy. Journal of Clinical Endocrinology and Metabolism 82: 1452-1457.

Hill, D.J., and V.K.M. Han. 1996. Fetal and placental development. Growth Factors and Cytokines in Health and Disease, Volume III. D. LeRoith, and C. Bondy. Greenwich, Connecticut: JAI Press. 1-53.

Hill, D.J., and V.K.M. Han. 1996. Role of growth factors in tissue development. Paediatrics and Perinatology. 2nd ed. P.D. Gluckman, and M.A. Heymann. Barking, UK: Keyword Publishing. 279-283.

Hill, D.J., R.J. Sedran, S.L. Brenner, and T.J. McDonald. 1997. Insulin-like growth factor-I (IGF-I) has a dual effect on insulin release from isolated, perifused adult rat islets of langerhans. Journal of Endocrinology 153: 15-25.

Kaplan, A.D., D.M. Kilkenny, D.J. Hill, and S.J. Dixon. 1996. Extracellular nucleotides act through P2U purinoceptors to elevate (Ca2+)I and enhance basic fibroblast growth factor-induced proliferation in sheep chondrocytes. Endocrinology 137: 4757-4766.

Kilkenny, D.M., and D.J. Hill. 1996. Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporally associated with the nuclear trafficking of FGF-2 proliferating epiphyseal growth plate chondrocytes. Endocrinology 137: 5078-5089.

Patel, V.A., D.J. Hill, M.C. Eggo, M.C. Sheppard, G.P. Becks, and A. Logan. 1996. Changes in the immunohistochemical localization of fibroblast growth factor-2, transforming growth factor ß1 and thrombospondin 1 are associated with early angiogenic events in the hyperplastic rat thyroid. Journal of Endocrinology 148: 485-499.

Walter, H.J., M. Berry, D.J. Hill, and A. Logan. 1997. Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine actions of IGF-I within wounds of the rat brain. Endocrinology 138: 3024-3034.

Wang, Y.F., G.P. Becks, and D.J. Hill. 1997. Degradation of insulin-like growth factor binding protein-3 (IGFBP-3) by proteases in cultured FRTL-5 rat thyroid cells. Journal of Endocrinology 152: 265-274.

 

HODSMAN, A.B.

Adachi, J.D., W.G. Bensen, J. Brown, D. Hanley, A.B. Hodsman, R. Josse, D. Kendler, B. Lentle, W. Olszynzki, L.-G. Ste-Marie, A. Tenehouse, A.A. Chines, A. Jovaisas, W.C. Sturridge, T.P. Anastassiades, J.G. Hanly, J.E. Pope, R. Dias, Z.D. Horowitz, and S. Pack. 1997. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. New England Journal of Medicine 337: 382-387.

Brenner, A.M., J.H. Toogood, and A.B. Hodsman. 1997. Steroid-induced osteoporosis in the asthmatic patient: diagnosis and management. Annals of Allergy, Asthma and Immunology Invited review.

Hodsman, A.B. 1997. Assessment of maintainance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat; utility of 2-Dimensional digital radiography to quantify bone mineral density as an index of change. Bone.

Hodsman, A.B., J. Adachi, and W. Olszynski. 1996. Use of bisphosphonates in the treatment of osteoporosis. Canadian Medical Association Journal (CMAJ) 155: 945-948. Report from the 1995 Consensus Conference of the Osteoporosis Society of Canada.

Hodsman, A.B., L.J. Fraher, R. Ostbye, J.D. Adachi, D.H. Taves, and D. Drost. 1997. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in post-menopausal women with osteoporosis. Journal of Clinical Endocrinology 82: 620-628.

Hodsman, A.B., L.J. Fraher, and P.H. Watson. 1997. Parathyroid Hormone: The Clinical Experience and Prospects. Anabolic Treatments for Osteoporosis. J.E. Whitfield, and P. Morley. Boca Raton, FL: CRC Press. 83-108.

Hodsman, A.B., and Scientific Advisory Board. 1996. Clinical practice guidelines for the diagnosis and management of osteoporosis. Canadian Medical Association Journal (CMAJ) 155: 1113-1129.

 

HOLLOMBY, D.J.

Hollomby, D.J. 1996. March is kidney month. Did you know high blood pressure is the second leading cause of kidney disease? Did you know there was a link between diabetes and kidney disease? 'Hamburger Disease' and Your Kidneys. Urinary tract infections and Your kidneys. Research and The Kidney Foundation of Canada. Kidney Foundation of Canada for the March Campaign Drive: Original articles written for and published by the Kidney Foundation of Canada for the March Campaign Drive .

 

HORGAN-BELL, C.

Nadarajah, S., B. Krafchik, C. Horgan-Bell, and C. Roifman . 1997. Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T cell abnormality. Pediatrics 99 (4): 630-633.

 

HOWSON-JAN, K.

DeKoter, R.P., M.F. Parsons, W.G. Fong, C.H. Lin, M.W. Khalil, K. Howson-Jan, and S.K. Singhal. 1997. Suppression of myelopoiesis and myeloid leukemia cell line proliferation by a novel bone marrow derived factor, Reptimed. Cellular Immunology 175: 120-127.

 

HRAMIAK, I.

Atkison, P.R., P. Zucker, I. Hramiak, T.L. Paul, J. Dupre, M.T. Behme, D.S.W. Scharp, P.E. Lacy, B.J. Olack, and C.R. Stiller. 1996. Continued insulin dependence despite normal range insulin sensitivity and insuline connecting peptide levels in a kidney/islet transplant patient. Diabetes Care 19 (3): 236-240.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 45: 1289-1298.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1997. Clustering of long-term complications in families with diabetes in The Diabetes Control and Complications Trial. Diabetes 46: 1829-1839.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1997. Hypoglycaemia in the DCCT. Diabetes 46: 271-286.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. Lifetime benefits and costs of intensive therapy as practised in the Diabetes Control and Complication Trial. JAMA 276: 1409-1415.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. Pregnancy outcomes in the DCCT. American Journal of Obstetrics and Gynecology 174: 1343-1353.

Dupre, J., M.T. Behme, I. Hramiak, and T.J. McDonald. 1997. Subcutaneous glucagon-like peptide I combined with insuline normalizes post cibal glycaemic excursions in IDDM. Diabetes Care 20: 381-384.

Hramiak, I., D. Finegood, and P.C. Adams. 1997. Factors affecting glucose tolerance in hereditary hemochromatosis. Clinical and Investigative Medicine 20: 110-118.

 

HUFF, M.W.

Huff, M.W., and J.R. Burnett. 1997. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion. Currents Opinions in Lipidology 8: 138-145.

Huff, M.W., D.B. Miller, B.M. Wolfe, P.W. Connelly, and C.G. Sawyez. 1997. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. Journal of Lipid Research 38: 1318-1333.

Whitman, S.C., D.B. Miller, B.M. Wolfe, R.A. Hegele, and M.W. Huff. 1997. Uptake of type III hypertriglyceridemic VLDL by macophages is enhanced by oxidation, especially after remnant formation. Arteriosclerosis, Thrombosis, and Vascular Biology 17: 1707-1715.

 

INWOOD, M.J.

Delorme, M.A., B. O'Keefe, M. Schaus, K. Mizzi, W.F. Brien, and M.J. Inwood. 1996. Investigation of a prolonged aPTT: a modified approach. Laboratory Hematology 2: 106-110.

Inwood, M.J. 1997. Visceral Bleeding (Chapter 13). Hemopilia . C.D. Forbes, L. Aledort, and R. Madhok. London, England: Chapman and Hall. 143-158.

 

JABLONSKY, G.

Cairns, J.A., S.T. Connolly, R. Roberts, M. Gent, The Canadian Amiodarone Myocaridal Infarction Arrhythmia Trial Investigators, and G. Jablonsky. 1997. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 349: 675-668.

GUSTO IB Investigators, and G. Jablonsky. 1996. The global use of strategies to open occluded coronary arteries: A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. New England Journal of Medicine 335: 775-782.

 

JEVNIKAR, A.M.

Anderson, C.C., R. Mukherjee, N.R. Sinclair, and A.M. Jevnikar. 1997. Hypogammaglobulinemia occurs in Fas deficient MRL-lpr mice following deletion of MHC class II molecules. Clinical and Experimental Immunology 109: 473-479.

Lazarovits, A.I., S. Poppema, Z. Zhang, M. Khandaker, C.E. Le Feuvre, S.K. Singhal, B.M. Garcia, M. Orgasa, A.M. Jevnikar, M.J. White, G. Singh, C.R. Stiller, and R. Zhong. 1996. Therapy of mouse renal allograft rejection by monoclonal antibody to CD45RB. Transplantation Proceedings 28: 3208-3209.

Li, X.-C., A.M. Jevnikar, and D. Grant. 1997. Expression of functional ICAM-1 and VCAM-1 adhesion molecules by an immortalized epithelial cell clone derived from the small intestine. Cellular Immunology 175: 58-66.

Ma, S.-W., D.-L. Zhao, Z.-Q. Yin, R. Mukherjee, B. Singh, H.-Y. Qin, C.R. Stiller, and A.M. Jevnikar. 1997. Transgenic plants expressing autoantigens to induce oral tolerance. Nature Medicine 3: 793-796.

 

KEENAN, S.P.

Jaeschke, R., M. Meade, G. Guyatt, S.P. Keenan, D. Cook, and The Evidenced Based Medicine in Critical Care Group. 1997. How to use diagnostic test articles in the ICU. Critical Care Medicine 25: 1514-1521.

Keenan, S.P., K.D. Busche, L.M. Chen, L. McCarthy, K.J. Inman, and W.J. Sibbald. 1997. A retrospective review of a large cohort of patients undergoing the process of withholding or withdrawal of life support: The real picture? Critical Care Medicine 25: 1324-1331.

Keenan, S.P., G.S. Doig, C.M. Martin, K.J. Inman, and W.J. Sibbald. 1997. Assessing the efficiency of the admission process to a critical care unit: Does the literature allow the use of benchmarking? Intensive Care Medicine 23: 574-580.

Keenan, S.P., P. Kernerman, D. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

Keenan, S.P., C.M. Martin, D.J. Cook, and W.J. Sibbald. 1997. An evidence-based learning and teaching tool: The critically appraised topic (CAT). Critical Care (Introductory Issue): 19-22.

 

KHALIL, M.W.

DeKoter, R.P., M.F. Parsons, W.G. Fong, C.H. Lin, M.W. Khalil, K. Howson-Jan, and S.K. Singhal. 1997. Suppression of myelopoiesis and myeloid leukemia cell line proliferation by a novel bone marrow derived factor, Reptimed. Cellular Immunology 175: 120-127.

Strutt, B.J., M.W. Khalil, and D.W. Killinger. 1996. Growth and differentiation of human adipose stromal cells in culture. Human Cell Culture Protocols. 5. G.E. Jones. 41-51.

Yang, K.P., M.W. Khalil, B.J. Strutt, and D.W. Killinger. 1997. 11ß-hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. Journal of Steroid Biochemistry and Molecular Biology 60: 247-253.

 

KILLINGER, D.W.

Killinger, D.W. 1997. 11ß-Hydroxysteroid Dehydrogenase 1 activity and Gene Expression in Human Adipose Stromal Cells: Effect on Aromatase Activity. Journal of Steroid Biochemistry and Molecular Biology 60: 247-253.

Killinger, D.W. 1997. Overexpression of The Growth-Hormone-Releasing Hormone Gene in Acromegaly-Associated Pituitary Tumors. American Journal of Pathology 151: 769-784.

Strutt, B.J., M.W. Khalil, and D.W. Killinger. 1996. Growth and differentiation of human adipose stromal cells in culture. Human Cell Culture Protocols. 5. G.E. Jones. 41-51.

Yang, K.P., M.W. Khalil, B.J. Strutt, and D.W. Killinger. 1997. 11ß-hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. Journal of Steroid Biochemistry and Molecular Biology 60: 247-253.

 

KLEIN, G.J.

Csanadi, Z., D.L. Jones, G.K. Wood, and G.J. Klein. 1997. Comparison of Single-Biphasic Versus Sequential-Biphasic Shocks on Defibrillation threshold in Pigs. PACE 20 (6,1): 1606-1612.

Epstein, A.E., W.M. Miles, D.G. Benditt, A.J. Camm, E.J. Darling, P.L. Friedman, A. Garson Jr., J.C. Harvey, G.A. Kidwell, G.J. Klein, P.A. Levine, F.E. Marchlinski, E.N. Prystowsky, and B.L. Wilkoff. 1996. Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations. Circulation 94: 1147-1166. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electophysiology.

Guiradon, G.M., C.M. Guiraudon, G.J. Klein, and R. Yee. 1997. Atrial fibrillation functional anatomy: Surgical Rationales. Ten Years of Radiofrequency Catheter Ablation. C. Moro, and J. Farre. Armonk, NY: Futura Publishing Co. Inc.

Guiraudon, G.M., C.M. Guiraudon, G.J. Klein, and R. Yee. 1997. Atrial fibrillation in the future: The surgeon's perspective. Nonpharmacological Management of Atrial Fibrillation, Volume 17. F.D. Murgatroyd, and A.J. Camm. Armonk, NY: Futura Publishing Co. Inc. 215-237.

Guiraudon, G.M., G.J. Klein, C.M. Guiraudon, and R. Yee. 1996. Surgical treatment of atrial fibrillation: What's new? Long-term follow-up. Heart Web 2 (1): 9611002.

Guiraudon, G.M., G.J. Klein, C. Guiraudon, and R. Yee. 1996. Intervenciones quirurgicas para el tratamiento de la fibrilacion auricular=Surgical interventions for atrial fibrillation. Ed Latina Electrocard 2 (2): 13-24.

Guiraudon, G.M., G.J. Klein, N. van Hemel, and C.M.J. Guiraudon. 1996. Atrial flutter: Lessons from surgical interventions (Musing on atrial flutter mechanism). PACE 19 (11, Part II): 1933-1938.

Guiraudon, G.M., G.J. Klein, and R. Yee. 1997. Approches chirurgicales de la fibrillation auriculaire. La fibrillation auriculaire. J.-V. Le Heuzey. Paris, France: Editions Louis Pariente. 377-396.

Guiraudon, G.M., G.J. Klein, and R. Yee. 1997. Surgical techniques in supraventricular tachycardias. Interventional Electrophysiology, Volume 18. I. Singer. Baltimore, MD: Williams and Wilkins. 565-593.

Guiraudon, G., C. Guiraudon, L.H. Chow, R. Yee, W.J. Kostuk, and G.J. Klein. 1996. Latissimus dorsi cardiomyoplasty combined with ICD implant. Les journees de la Pitie: Transplantation cardiaque et pulmonaire, cardiomyoplastie, assistance circulatoire. C. Cabrol, I. Gandjbakhch, and A. Pavie. Montpellier, France: R & J Editions Medicales and Sauramps. 167-170.

Kerr, C.R., The Canadian Registry of Atrial Fibrillation (CARAF) Investigators, and G.J. Klein. 1997. Who wants to be treated for atrial fibrillation? Relationship of clinical variables to symptoms. Nonpharmalogical Management of Atrial Fibrillation, Volume 2. F.D. Murgatroyd, and A.J. Camm. Armonk, NY: Futura Publishing Co. Inc. 15-22.

Kerr, C., J. Boone, S. Connolly, M. Greene, G.J. Klein, R. Sheldon, and M. Talajic. 1996. Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation. European Heart Journal 17 (C): 48-51.

Klein, G.J. 1997. Sycope. Cardiology Clinics of North America 15 (2).

Krahn, A.D., G.J. Klein, G. Guiraudon, and R. Yee. 1997. Ablation of posteroseptal accessory pathways (Chapter 8). Interventional Electrophysiology. I. Singer. Baltimore, MD: Williams and Wilkins. 231-252.

Krahn, A.D., G.J. Klein, C.R. Kerr, J. Boone, R. Sheldon, M. Green, M. Talajic, X. Wang, and S. Connolly. 1996. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? Archives of Internal Medicine 156: 2221-2224.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent Sycope: Experience with an Implantable Loop Recorder. Cardiology Clinics 15 (2): 313-326.

Krahn, A.D., G.J. Klein, and R. Yee. 1996. Recurrent unexplained syncope: Diagnostic and therapeutic approach. Canadian Journal of Cardiology 12 (10): 989-994.

Krahn, A.D., G.J. Klein, R. Yee, and The Mansfield Polaris Investigators. 1997. Time dependent change in fast pathway refractoriness after slow pathway ablation in patients with atrioventricular node reentrant tachycardia. Canadian Journal of Cardiology 13 (6): 583-588.

Krahn, A.D., G.J. Klein, R. Yee, and C. Norris. 1997. Maturation of the sensed electrogram amplitude over time in a new subcutaneous implantable loop recorder. PACE 20: 1686-1690.

Morillo, C.A., G.J. Klein, and D.L. Jones. 1996. Effects of autonomic modulation on ventricular fibrillation and internal cardiac defibrillation thresholds in pigs. PACE 19: 1355-1362.

Morillo C.A., G.J. Klein, R. Yee, and G.M. Guiraudon. 1997. The Wolff-Parkinson-White syndrome. Clinical Approaches to Tachyarrhythmias. A.J. Camm. Armonk, NY: Futura Publishing Company, Inc. 6.

Rosenbaum, M., G.J. Klein, A.D. Krahn, M. Basta, C. Le Feuvre, and R. Yee. 1997. Utility of full electrophysiological study before accessory pathway ablation in Wolff-Parkinson-White syndrome. Canadian Journal of Cardiology 13 (4): 359-362.

Simons, G.R., G.J. Klein, and A. Natale. 1997. Ventricular Tachycardia: Pathophysiology and Radiofrequency Catheter Ablation. PACE 20 (2): 534-551.

 

KOSTUK, W.J.

Bussieres, L.M., P.W. Pflugfelder, A.W. Taylor, D. Ahmad, C. Weernink, and W.J. Kostuk. 1997. Changes in cardiopulmonary responses to exercise after cardiac transplantation in patients enrolled in an early rehabilitation program. Canadian Respiratory Journal 4 (2): 81-87.

Bussieres, L.M., P.W. Pflugfelder, A.W. Taylor, E.G. Noble, and W.J. Kostuk. 1997. Changes in skeletal muscle morphology and biochemistry after cardiac transplantation. American Journal of Cardiology 79: 630-634.

Guiraudon, G., C. Guiraudon, L.H. Chow, R. Yee, W.J. Kostuk, and G.J. Klein. 1996. Latissimus dorsi cardiomyoplasty combined with ICD implant. Les journees de la Pitie: Transplantation cardiaque et pulmonaire, cardiomyoplastie, assistance circulatoire. C. Cabrol, I. Gandjbakhch, and A. Pavie. Montpellier, France: R & J Editions Medicales and Sauramps. 167-170.

Levine, T.B., The MACH-1 Investigators, and W.J. Kostuk. 1997. The design of the morality assessment in congestive heart failure trial (MACH-1, Mibefridil). Clinical Cardiology 20: 320-326.

 

KOVACS, M.J.

Berenson, J.R., A. Lichteastein, L. Porter, M.A. Dimopoulous, R. Bordoni, A. George, A. Lipton, A. Keller, O. Ballester, M.J. Kovacs, H.A. Blacklock, R. Bell, J. Simeone, D.J. Reitsma, M. Heffernan, J. Seaman, and R.D. Knight. 1996. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. New England Journal of Medicine 334: 488-493.

The Columbus Investigators, and M.J. Kovacs. 1997. Low molecular weight heparin is an effective and safe treatment for deep-vein thrombosis and pulmonary embolism. New England Journal of Medicine 337 (10): 657-667.

Gavura, S., C.D. Bayliff, and M.J. Kovacs. 1997. Evaluation of a heparin nomogram in the treatment of keep vein thrombosis and pulmonary embolism. Journal of Canadian Hospital Pharmacy 50: 115-119.

Kovacs, M.J., M. Keeney, K. Weir, and K. MacKinnon. 1996. A comparison of three methods of measuring low molecular weight heparin activity post-total knee or hip arthroplasty. Laboratory Hematology 2: 111-114.

Levine, M., M. Gent, J. Hirsh, J. Leclerc, D. Anderson, J. Weitz, J. Ginsberg, A.G. Turpie, C. Demers, M.J. Kovacs, W. Geerts, J. Kassis, L. Desjardins, J. Cusson, M.K. Cruickshank, P. Powers, W.F. Brien, S. Haley, and A. Willan. 1996. A comparison of low-molecular-weight heparin administered primarily at home with unfractioned heparin administered in the hospital for proximal deep-vein thrombosis. New England Journal of Medicine 334: 677-681.

Wylie, A.R.J., C.D. Bayliff, and M.J. Kovacs. 1997. Myoclonus due to chlorambucil in two adults with lymphoma. Annals of Pharmacotherapy 31: 171-174.

 

KRAHN, A.D.

Krahn, A.D., G.J. Klein, G. Guiraudon, and R. Yee. 1997. Ablation of posteroseptal accessory pathways (Chapter 8). Interventional Electrophysiology. I. Singer. Baltimore, MD: Williams and Wilkins. 231-252.

Krahn, A.D., G.J. Klein, C.R. Kerr, J. Boone, R. Sheldon, M. Green, M. Talajic, X. Wang, and S. Connolly. 1996. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? Archives of Internal Medicine 156: 2221-2224.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent Sycope: Experience with an Implantable Loop Recorder. Cardiology Clinics 15 (2): 313-326.

Krahn, A.D., G.J. Klein, and R. Yee. 1996. Recurrent unexplained syncope: Diagnostic and therapeutic approach. Canadian Journal of Cardiology 12 (10): 989-994.

Krahn, A.D., G.J. Klein, R. Yee, and The Mansfield Polaris Investigators. 1997. Time dependent change in fast pathway refractoriness after slow pathway ablation in patients with atrioventricular node reentrant tachycardia. Canadian Journal of Cardiology 13 (6): 583-588.

Krahn, A.D., G.J. Klein, R. Yee, and C. Norris. 1997. Maturation of the sensed electrogram amplitude over time in a new subcutaneous implantable loop recorder. PACE 20: 1686-1690.

Rosenbaum, M., G.J. Klein, A.D. Krahn, M. Basta, C. E. Le Feuvre, and R. Yee. 1997. Utility of full electrophysiological study before accessory pathway ablation in Wolff-Parkinson-White syndrome. Canadian Journal of Cardiology 13 (4): 359-362.

 

LAROCQUE, B.J.

Lapointe, H.J., J.E. Armstrong, and B.J. Larocque. 1997. A Clinical Decision Making Framework for the Medically Compromised Patient. Canadian Dental Association Journal 63 (7): 510-516.

Larocque, B.J., K. Gilbert, and W.F. Brien. 1997. A point score system to predict the likelihood of blood transfusion following hip or knee arthroplasty. Transfusion 37: 463-467.

 

LAURIER, L.G.

Rajakumar, N., L.G. Laurier, H.B. Niznik, and A.J. Stoessal. 1997. Effects of intra-striatal infusions of D2 receptor antisense oligonucleotides on apomorphine-induced behaviours in the rat. Synapse 26: 199-208.

 

LAZAROVITS, A.I.

Auersvald, L.A., D.M. Rothstein, S.C. Oliveira, C.Q. Khuong, H. Onodera, A.I. Lazarovits, and G.P. Basadonna. 1997. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation 63: 1355-1369.

Brezinschek, R.I., H.P. Brezinschek, A.I. Lazarovits, P.E. Lipsky, and N. Oppenheimer-Marks. 1996. Expression of the ß7 integrin by human endothelial cells. American Journal of Pathology 149: 1651-1660.

Dolcetti, R., R. Giardini, C. Doglioni, R. Cariati, F. Pomponi, C. D'Orazi, S. Rao, A.I. Lazarovits, E.C. Butcher, and M. Boiocchi. 1997. 4ß7 integrin expression is associated with the leukemic evolution of human and murine T cell lymphoblastic lymphomas. American Journal of Pathology 150: 1595-1605.

Drillenburg, P., K. van der Voort, G. Koopman, B. Dragnosics, J.H.J.M. van Krieken, P. Kluin, J. Meenan, A.I. Lazarovits, T. Radaszkiewicz, and S.T. Pals. 1996. Preferential expression of the mucosal homing receptor integrin 4ß7. American Journal of Pathology 150: 919-927.

Farstad, I.N., T.S. Halstensen, B. Lien, P.J. Kilshaw, A.I. Lazarovits, and P. Brandtzaeg. 1996. Distribution of ß7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 89: 227-237.

Geissmann, F., C. Thomas, J.F. Emile, M. Micheau, D. Canioni, N. Cerf-Bensussan, A.I. Lazarovits, and N. Brousse. 1996. Digestive tract involvement in Langerhans cell hystiocytosis. Journal of Pediatrics 129: 836-845.

Kantele, A., J.M. Kantele, E. Savilahti, M. Westerholm, H. Arvilommi, A.I. Lazarovits, E.C. Butcher, and P.H. Makela. 1997. Homing potentials of circulating lymphocytes in humans depend on the site of activation. Journal of Immunology 158: 574-579.

Lazarovits, A.I., N. Muirhead, and L. Sharma. 1997. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: Analysis beyond four years. Transplantation Proceedings 29: 323-324.

Lazarovits, A.I., S. Poppema, Z. Zhang, M. Khandaker, C.E. Le Feuvre, S.K. Singhal, B.M. Garcia, N. Ogasa, A.M. Jevnikar, M.J. White, G. Singh, C.R. Stiller, and R.Z. Zhong. 1996. Therapy for mouse renal allograft rejection by monoclonal antibody to CD45RB. Transplantation Proceedings 28: 3208-3209.

Quiding-Jarbrink, M., I. Nordstrom, G. Granstrom, A. Kilander, M. Jertborn, E.C. Butcher, A.I. Lazarovits, J. Holmgren, and C. Czerkinsky. 1997. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric and nasal immunizations A molecular basis for the compartmentalization of effector B cell responses. Journal of Clinical Investigation 99: 1281-1286.

Yang, Y., J.E.B. Harrison, C.G. Print, K. Lehnert, M. Sammar, A.I. Lazarovits, and G.W. Krissansen. 1996. Interaction of monocytoid cells with the mucosal addressin MAdCAM-1 via VLA-4 and LPAM-1. Immunology and Cell Biology 74: 383-393.

Zhang, Z., L. Zhu, D. Quan, B. Garcia, N. Ozcay, J. Duff, C.R. Stiller, A.I. Lazarovits, D. Grant, and R. Zhong. 1996. The pattern of liver, kidney, heart and intestine allograft rejection in different mouse strain combinations. Transplantation 62: 1267-1272.

 

LE FEUVRE, C.E.

Lazarovits, A.I., S. Poppema, Z. Zhang, M. Khandaker, C.E. Le Feuvre, S.K. Singhal, B.M. Garcia, M. Orgasa, A.M. Jevnikar, M.J. White, G. Singh, C.R. Stiller, and R. Zhong. 1996. Therapy of mouse renal allograft rejection by monoclonal antibody to CD45RB. Transplantation Proceedings 28: 3208-3209.

Rosenbaum, M., G.J. Klein, A.D. Krahn, M. Basta, C. E. Le Feuvre, and R. Yee. 1997. Utility of full electrophysiological study before accessory pathway ablation in Wolff-Parkinson-White syndrome. Canadian Journal of Cardiology 13 (4): 359-362.

 

LEASA, D.J.

Leasa, D.J., and W.J. Sibbald. 1997. The rationing of critical care services in Canada. Current Opinion in Critical Care : 317-321.

 

LEWIS, J.F.

Borron, P., R. Veldhuizen, L.J. Fraher, F. Possmayer, A.N. Caveney, J.F. Lewis, K. Inchley, and R.G. McFadden. 1996. Bovine surfactant associated protein-A inhibits phytohaemagglutonin stimulated human lymphocytes, proliferation and IL-2 production. American Journal of Respiratory Cell and Molecular Biology 15: 115-121.

Ito, Y., R. Veldhuizen, L.J. Yao, L. McCaig, A. Bartlett, and J.F. Lewis. 1997. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. American Journal of Respiratory and Critical Care Medicine 155 (2): 493-499.

Novick, R.J., A. Gilpin, K. Gehman, I. Ali, R. Veldhuizen, J.C. Duplan, L.M. Denning, F. Possmayer, D. Bjarneson, and J.F. Lewis. 1996. Mitigation of injury in canine lung grafts by exogenous surfactant therapy. Journal of Thoracic and Cardiovascular Surgery 113 (2): 342-353.

 

LINDSAY, R.M.

Lindsay, R.M. 1996. The roles of dialysis prescription and nutritional status on the outcome of dialysis patients. Nephrologisches Jahrespräch : 32-37.

Lindsay, R.M., P.G. Blake, P. Malek, G. Posen, B. Martin, and E. Bradfield. 1997. Haemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. American Journal Kidney Diseases 30 (4): 475-482.

Lindsay, R.M., and E. Spanner. 1997. Adequacy of haemodialysis in the elderly. Geriatric Nephrology and Urology 7 (3).

 

LLOYD, D.A.

Lloyd, D.A. 1997. Management of nonulcer dyspepsia. Canadian Journal of Continuing Medical Education : 77-84.

Valberg, L.S., and D.A. Lloyd. 1997. Multimedia program for student and resident education. (Videotape).

 

LOHMANN, R.C.

Lohmann, R.C. 1997. Value of Blood Transfusion and Transfusion Guidelines. CSTM Bulletin 9 (1): 14-17.

Rusthoven, J.R., R.C. Lohmann, et al. 1996. Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine and cisplatin with and without tamoxifenin patients with metastatic melanoma. Journal of Clinical Oncology 14 (7): 2083-2090.

 

LUCAS, A.R.

Bauer, J., X.Y. Jiang, Y. Wen, W.D. Yan, E. Dai, L.Y. Liu, J. Tulip, and A.R. Lucas. 1996. Comparative study of Nd: YAG laser angioplasty at 106 m, 132 m, and 144 m wave lengths: Decreased vascular spasm and early mortality with 144 m laser ablation. Lasers In Surgery and Medicine 19: 299-310.

Dai, E., D. Wishart, S. Khoury, C. Kay, B.I. Jugdutt, J. Tulip, and A.R. Lucas. 1996. Laser-induced fluorescence: Quantitative analysis of atheroclerotic plaque chemical content in human aorta. SPIE, Laser Surgery 2671: 90-103.

Graham, K.A., A.S. Lalani, J.L. Macen, T.L. Ness, M. Barry, L.Y. Liu, A.R. Lucas, I. Clark-Lewis, R.W. Moyer, and G. McFadden. 1997. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229: 12-24.

Jugdutt, B.I., A.R. Lucas, M.I. Khan, and G.E. Blinston. 1997. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction. Canadian Journal of Cardiology 13 (7): 657-668.

Liu, L.Y., E. Dai, M. Lundstrom Hobman, D. Kolodziejczyk, and A.R. Lucas. 1996. Animal models of Restenosis: Myth or reality. Current Pharmacy Design 2: 553-584.

Lucas, A.R., L.Y. Liu, J. Macen, P. Nash, E. Dai, M. Stewart, K. Graham, W. Etches, L. Boshkov, P.N. Nation, M. Lundstrom Hobman, and G. McFadden. 1996. Virus-encoded serine proteinase inhibitor, SERP-1, inhibits atherosclerotic plaque development after balloon angioplasty. Circulation 94 (11): 2890-2900.

Lucas, A.R., Y. Wen, X.Y. Jiang, L.Y. Liu, W.D. Yan, J. Bauer, W. Schneider, J. Tulip, A. Chagpar, E.P.M. Dai, P. Montague, M. Garbutt, and M.J. Radosavijevic. 1996. Development of an avian model for restenosis. Atherosclerosis 119: 17-41.

Maksymowych, W.P., N. Nation, P. Nash, J. Macen, A.R. Lucas, G. McFadden, and A.S. Russell. 1996. Amelioration of established antigen-induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor. Journal of Rheumatology 23: 878-882.

Mossman, K., P. Nation, J. Mason, M. Garbutt, A.R. Lucas, and G. McFadden. 1996. Myxoma virus M-T7, a secreted homologue of the interferon gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbbits. Virology 215: 17-30.

 

MADRENAS, J.

Gao, J.X., J. Madrenas, W. Zeng, R. Zhong, and D. Grant. 1997. Generation of dendritic cell-like antigen-presenting cells in long-term mixed leucocyte culture: phenotypic and functional studies. Immunology 91: 135.

Madrenas, J., L. Chau, J. Smith, J.A. Bluestone, and R.N. Germain. 1997. The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide-MHC Molecule Ligands. Journal of Experimental Medicine 185: 219.

Madrenas, J., R.H. Schwartz, and R.N. Germain. 1996. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proceedings of the National Academy of Sciences USA 93: 9736.

 

MAHMOUDI, M.

Mahmoudi, M., J.Y. Edwards, D.A. Bell, and E. Cairns. 1997. V region gene analysis of human IgM hybridoma monoclonal anti-Sm antibodies. Lupus 6: 578-590.

Sawchuk, D.J., M. Mahmoudi, E. Cairns, and N.R.S. Sinclair . 1996. Nonsynonymous mutations in a Fc-receptor structural gene in NZB mice. Immunogenetics 43: 112-114.

 

MAHON, J.L.

Dupre, J., J.L. Mahon, and C.R. Stiller. 1997. Prevention of development of progression of B-cell damage in insulin-dependent diabetes mellitus. Textbook of Diabetes, Volume 82.1. J. Pickup, and G. Williams. Oxford: Blackwell Scientific Publications. 82.11.

Mahon, J.L., and J. Dupre. 1997. The limitations of clinical trials of prevention for insulin dependent diabetes mellitus. Diabetes Care 20: 1027-1033.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. Patient directed hypertention management. American Journal of Hypertension 10: 58-67.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. American Journal of Hypertension 10: 58-67.

 

MARTIN, C.M.

Farquhar, I., C.M. Martin, C. Lam, R. Potter, C. Ellis, and W.J. Sibbald. 1996. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. Journal of Surgical Research 1: 190-196.

Fitzgerald, R.D., C.M. Martin, G.E. Dietz, G.S. Doig, R.F. Potter, and W.J. Sibbald. 1997. Transfusing RBCs stored in CPDA-1 for 28 days fails to improve tissue oxygenation in rats. Critical Care Medicine 25: 726-732.

Hebert, P.C., G. Wells, M. Tweeddale, C.M. Martin, J. Marshall, B. Pham, M. Blajchman, I. Schweitzer, and G. Pagliarello. 1997. Does transfusion practice affect mortality in critically-ill patients? American Journal of Respiratory and Critical Care Medicine 155: 1618-1623.

Keenan, S.P., G.S. Doig, C.M. Martin, K.J. Inman, and W.J. Sibbald. 1997. Assessing the efficiency of the admission process to a critical care unit: Does the literature allow the use of benchmarking? Intensive Care Medicine 23: 574-580.

Keenan, S.P., P. Kernerman, D. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

Keenan, S.P., C.M. Martin, D.J. Cook, and W.J. Sibbald. 1997. An evidence-based learning and teaching tool: The critically appraised topic (CAT). Critical Care (Introductory Issue): 19-22.

Martin, C.M., and W.J. Sibbald. 1996. Oxygen delivery in critically ill patients. Current Opinion in Critical Care 2: 386-390.

Sielenkemper, A.W., I.H. Chin-Yee, C.M. Martin, and W.J. Sibbald. 1996. Diapirin cross-linked hemoglobin improves system oxygen uptake in oxygen supply-dependent septic rats. American Journal of Respiratory and Critical Care Medicine 154 (3).

Willoughby, R.P.N., K.A. Harris, M.W. Carson, C.M. Martin, M. Troster, G. DeRose, W.G. Jamieson, and R.F. Potter. 1996. Intestinal mucosal permeability to 51Cr-ethylenediaminetetraacetic acid is increased after bilateral lower extremity ischemia-reperfusion in the rat. Surgery 120: 547-553.

Yu, P., D.R. Boughner, W.J. Sibbald, J. Keys, J. Dunmore, and C.M. Martin. 1997. Myocardial collagen changes and edema in rats with hyperdynamic sepsis. Critical Care Medicine 25: 657-662.

 

MAZZA, J.A.

Boulet, L.P., M. Laviolette, S. Boucher, J.A. Mazza, D.W. Moote, et al. 1997. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to moderate asthma: A Canadian multicenter study. Journal of Allergy and Clinical Immunology 99 (1): 14-21.

Day, J., M. Alexander, M. Drouin, C. Frankish, J.A. Mazza, D.W. Moote, P. Patel, H. Ramsdale, and W. Yang. 1997. Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis. American Journal of Rhinology 11 (1): 77-83.

Estelle, F., Simons, J.A. Mazza, and D.W. Moote. 1997. A comparison of beclomethasone, salmeterol and placebo in children with asthma. New England Journal of Medicine 337: 23.

Fisher, D., and J.A. Mazza. 1997. Penicillin allergy. Parkhurst Exchange 5.

 

MCCAIG, L.

Ito, Y., R. Veldhuizen, L.J. Yao, L. McCaig, A. Bartlett, and J.F. Lewis. 1997. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. American Journal of Respiratory and Critical Care Medicine 155 (2): 493-499.

 

MCCORMACK, D.G.

Keenan, S.P., P. Kernerman, D. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

McCormack, D.G. 1996. Effects of lung injury on the pulmonary circulation. The Pulmonary Circulation: A Handbook for Clinicians. A.J. Peacock. London, UK: Chapman and Hall. 483-489.

Pope, J.E., and D.G. McCormack. 1996. A case of atypical and recurrent Lofgren's syndrome. Journal of Clinical Rheumatology 6: 354-357.

 

MCDONALD, J.W.D.

Atkinson, K.A., J.W.D. McDonald, B. Lamba, and B.G. Feagan . 1997. Intravenous cyclosporine for severe attacks of ulcerative colitis: A survey of Canadian gastroenterologists. Canadian Journal of Gastroenterology 11 (7): 583-587.

Feagan, B.G., and J.W.D. McDonald. 1997. Cyclosporine in Crohn's disease. Lancet 349: 1328.

Feagan, B.G., and J.W.D. McDonald. 1997. Medical therapy for inflammatory bowel disease. Current Opinion in Gastroenterology 13: 307-311.

 

MCDONALD, T.J.

Dupre, J., M.T. Behme, I. Hramiak, and T.J. McDonald. 1997. Subcutaneous glucagon-like peptide I combined with insuline normalizes post cibal glycaemic excursions in IDDM. Diabetes Care 20: 381-384.

Hill, D.J., R.J. Sedran, S.L. Brenner, and T.J. McDonald. 1997. Insulin-like growth factor-I (IGF-I) has a dual effect on insulin release from isolated, perifused adult rat islets of langerhans. Journal of Endocrinology 153: 15-25.

Koopmans, H.S., T.J. McDonald, and M. DiGirolamo. 1997. Morphological and metabolic changes associated with large differences in daily food intake in crossed-intestines rats. Physiology and Behaviour 62: 129-136.

Moneta, N.A., T.J. McDonald, and M.A. Cook. 1997. Endogenous adenosine inhibits evoked substance P release from enteric nerves in perifused networks of myenteris ganglia. American Journal of Physiology 272: G38-G45.

Wang, Y.F., Y.K. Mao, Q. Xiao, E.E. Daniel, K.R. Borkowski, and T.J. McDonald. 1997. The distribution of NPY-containing nerves and the catecholamine contents of canine enteric nerve plexuses. Peptides 18: 221-234.

 

MCFADDEN, R.G.

Borron, P., R. Veldhuizen, L.J. Fraher, F. Possmayer, A.N. Caveney, J.F. Lewis, K. Inchley, and R.G. McFadden. 1996. Bovine surfactant associated protein-A inhibits phytohaemagglutonin stimulated human lymphocytes, proliferation and IL-2 production. American Journal of Respiratory Cell and Molecular Biology 15: 115-121.

 

MCMANUS, R.M.

McManus, R.M. 1996. Where the Rubber hits the Road: Foot care and Diabetes. Canadian Journal of Continuing Medical Education : 99-104.

McManus, R.M. 1996. Winter and Exercise. Diabetes London (28): 1.

 

MELENDEZ, L.J.

Finnie, K.J.C., and L.J. Melendez. 1997. Chest pain and left bundle branch block. Canadina Journal of Diagnosis 14 (5): 31-32.

Finnie, K.J.C., and L.J. Melendez. 1996. The falling sickness? Canadian Journal of Diagnosis 13 (9): 27-28.

Finnie, K.J.C., and L.J. Melendez. 1996. A light problem. Canadian Journal of Diagnosis 13 (8): 29-32.

Finnie, K.J.C., and L.J. Melendez. 1997. A little excitement. Canadian Journal of Diagnosis 14 (1): 33-35.

Finnie, K.J.C., and L.J. Melendez. 1996. A paroxysmal tachycardia. Canadian Journal of Diagnosis 13 (11): 31-32.

Finnie, K.J.C., and L.J. Melendez. 1997. PVCs? Canadian Journal of Diagnosis 14 (3): 35-37.

Melendez, L.J., and K.J.C. Finnie. 1996. Another type? Canadian Journal of Diagnosis 13 (12): 35-38.

Melendez, L.J., and K.J.C. Finnie. 1997. Please don't follow me. Canadian Journal of Diagnosis 14 (6): 31-32.

Melendez, L.J., and K.J.C. Finnie. 1997. Postoperative dysrhythmia. Canadian Journal of Diagnosis 14 (4): 31-32.

Melendez, L.J., and K.J.C. Finnie. 1996. Sudden severe dyspnea. Canadian Journal of Diagnosis 13 (7): 29-32.

Melendez, L.J., and K.J.C. Finnie. 1996. Through the narrow gate. Canadian Journal of Diagnosis 13 (10): 31-32.

Melendez, L.J., and K.J.C. Finnie. 1997. What, where and how? Canadian Journal of Diagnosis 14 (2): 33-34.

 

MOOTE, D.W.

Boulet, L.P., M. Laviolette, S. Boucher, J.A. Mazza, D.W. Moote, et al. 1997. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to moderate asthma: A Canadian multicenter study. Journal of Allergy and Clinical Immunology 99 (1): 14-21.

Day, J., M. Alexander, M. Drouin, C. Frankish, J.A. Mazza, D.W. Moote, P. Patel, H. Ramsdale, and W. Yang. 1997. Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis. American Journal of Rhinology 11 (1): 77-83.

Estelle, F., Simons, J.A. Mazza, and D.W. Moote. 1997. A comparison of beclomethasone, salmeterol and placebo in children with asthma. New England Journal of Medicine 337: 23.

Moote, D.W. 1997. Allergic Rhinitis. Therapeutic Choices, Canadian Pharmaceutical Association. Canadian Pharmaceutical Association.

Moote, D.W. 1996. Canadian Asthma Consensus Conference: Summary of Recommendations. Canadian Respiratory Journal 3 (2): 89-100.

 

MUIRHEAD, N.

Barrett, B.J., P.S. Parfrey, J. Morgan, P. Barre, A. Fine, M.B. Goldstein, S.P. Handa, K.K. Jindal, C.M. Kjellstrand, A. Levin, H.M. Mandin, N. Muirhead, and R.M. Richardson. 1997. Prediction of early death in end-stage renal disease patients starting dialysis. American Journal of Kidney Disease 29: 214-222.

Keown, P.A., D. Landsberg, P. Halloran, A. Shoker, D. Rush, J. Jeffrey, D. Russell, C.R. Stiller, N. Muirhead, E. Cole, L. Paul, R. Zaltzman, P. Loertscher, Daloze. P., R. Dandevino, A. Boucher, P. Handa, J. Lauren, P. Belitsky, P. Parkfrey, and The Canadian Neural Transplantation Study Group. 1996. A randomized, prospective multicentre pharmacoepidemiologic study of cyclosporine microemulsion in stable renal grafts recipients. Transplantation 62: 1744-1752.

Keown, P.A., D. Landsberg, P. Halloran, A. Shoker, D. Rush, J. Jeffrey, D. Russell, C.R. Stiller, N. Muirhead, E. Cole, L. Paul, R. Zaltzman, P. Loertscher, Daloze. P., R. Dandevino, A. Boucher, P. Handa, J. Lauren, P. Belitsky, P. Parkfrey, and The Canadian Neural Renal Transplantation Group. 1997. Reduced pharmokinetic variability in renal graft recipients treated with cyclosporine microemulsion. Results of a randomized, prospective pharmacoepidemiologic comparison. Transplantation.

Keown, P.A., D. Landsberg, P. Halloran, A. Shoker, D. Rush, J. Jeffrey, D. Russell, C.R. Stiller, N. Muirhead, E. Cole, L. Paul, R. Zaltzman, P. Loertscher, Daloze. P., R. Dandevino, A. Boucher, P. Handa, J. Lauren, P. Belitsky, P. Parkfrey, and The Canadian Neural Renal Transplantation Group. 1997. Safety and tolerability of cyclosporine and clyclosporine microemulsion during 18 months of follow-up in stabel renal transplant recipients. Transplantation.

Lazarovits, A.I., N. Muirhead, and L. Sharma. 1997. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: Analysis beyond four years. Transplantation Proceedings 29: 323-324.

Stehman-Breen, C., N. Muirhead, D. Thorning, and D. Sherrard. 1997. Secondary hyperparathyroidism complicated by parathyromatosis. American Journal of Kidney Diseases 28: 502-507.

 

MUKHERJEE, R.

Anderson, C.C., R. Mukherjee, N.R. Sinclair, and A.M. Jevnikar. 1997. Hypogammaglobulinemia occurs in Fas deficient MRL-lpr mice following deletion of MHC class II molecules. Clinical and Experimental Immunology 109: 473-479.

Ma, S.-W., D.-L. Zhao, Z.-Q. Yin, R. Mukherjee, B. Singh, H.-Y. Qin, C.R. Stiller, and A.M. Jevnikar. 1997. Transgenic plants expressing autoantigens to induce oral tolerance. Nature Medicine 3: 793-796.

 

PATERSON, N.A.M.

Toogood, J.H., N.A.M. Paterson, and F.A. White. 1997. Corticosteroids and Anti-Metabolites. Allergy. A.P. Kaplan. Philadelphia, PA: W.B.Saunders Co. 706-725.

 

PATRICK, L.

Patrick, L. (1997). Recovery From Your Heart Attack. Meducom International: A patient education booklet.

 

PAYTON, K.B.

Payton, K.B. 1996. Of Little Green Boxes and CME: Editorial. The Canadian Journal of Continuing Medical Education (August)

Vingilis, E., U. Brown, R. Koeppen, B. Hennen, M. Bass, K.B. Payton, J. Downe, and M. Stewart. 1997. Evaluation of a cold/flu self-care public education campaign. Health Education Research Theory and Practice : 12.

 

PFLUGFELDER, P.W.

Bussieres, L.M., P.W. Pflugfelder, A.W. Taylor, D. Ahmad, C. Weernink, and W.J. Kostuk. 1997. Changes in cardiopulmonary responses to exercise after cardiac transplantation in patients enrolled in an early rehabilitation program. Canadian Respiratory Journal 4 (2): 81-87.

Bussieres, L.M., P.W. Pflugfelder, A.W. Taylor, E.G. Noble, and W.J. Kostuk. 1997. Changes in skeletal muscle morphology and biochemistry after cardiac transplantation. American Journal of Cardiology 79: 630-634.

 

PICKERING, J.G.

Chow, L.H., S. Huh, J. Jiang, R. Zhong, and J.G. Pickering . 1996. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation 94 (12): 3079-3082.

Nikol, S., N. Murakami, J.G. Pickering, M. Kearney, G. Leclerc, B. Hofling, J.M. Isner, and L. Weir. 1997. Differential expression of nonmuscle myosin II isoforms in human athersosclerotic plaque. Atherosclerosis 130: 71-85.

Pickering, J.G., C.M. Ford, and L.H. Chow. 1996. Evidence for rapid accumulation and persistently disordered architecture of fibrillar collagen in human coronary restenosis lesions. American Journal of Cardiology 78: 633-637.

Pickering, J.G., C.M. Ford, B. Tang, and L.H. Chow. 1997. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells: evidence for repressed collagen production and activated degradative capacity. Arteriosclerosis, Thrombosis, and Vascular Biology 17 (3): 475-482.

Pickering, J.G., S. Uniyal, C.M. Ford, T. Chau, M.A. Laurin, L.H. Chow, C.G. Ellis, J. Fish, and B.M.C. Chan. 1997. Fibroblast growth factor-2 potentiates vascular smooth muscle cell migration to platelet-derived growth factor: Upregulation of integrin and disassembly of actin filaments. Circulation Research 80 (5): 627-637.

 

PONICH, T.

Ponich, T. 1997. What do you do about an upset stomach. The Health Care Book - The Complete Guide to Healthcare Services. 1-4.

 

POPE, J.E.

Adachi, J.D., W.G. Bensen, J. Brown, D. Hanley, A.B. Hodsman, R. Josse, D. Kendler, B. Lentle, W. Olszynzki, L.-G. Ste-Marie, A. Tenehouse, A.A. Chines, A. Jovaisas, W.C. Sturridge, T.P. Anastassiades, J.G. Hanly, J.E. Pope, R. Dias, Z.D. Horowitz, and S. Pack. 1997. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. New England Journal of Medicine 337: 382-387.

Beattie, C., F. Beaudet, P. Davis, P. Docherty, M. Easterbrook, A. Fitzcharles, D.A. Gordon, B. Koehler, H.A. Menard, J.E. Pope, D. Smith, C. Chorne, and P. Turcotte. 1997. Workshop report: Antimalarial workshop. Journal of Rheumatology 24: 1393-1395.

Chopra, N., and J.E. Pope. 1997. Is rheumatoid arthritis breaking the connection? Canadian Journal of Diagnosis 14 (64-69).

Pope, J.E. 1996. Step-care treatment of rheumatoid arthritis. Canadian Journal of Continuing Medical Education 8: 55-63.

Pope, J.E. 1996. Treatment of systemic sclerosis. Clinics in North America 22: 893-907.

Pope, J.E. 1996. The use of tetracycline in rheumatoid arthritis. Journal of the Canadian Rheumatology Association 6: 8-10.

Pope, J.E., and D.G. McCormack. 1996. A case of atypical and recurrent Lofgren's syndrome. Journal of Clinical Rheumatology 6: 354-357.

 

PREIKSAITIS, H.G.

Preiksaitis, H.G. 1997. Invited commentary on: Influence of surgery on deglutative upper esophageal sphincter mechanics in Zenker's diverticulum, by Shaw, D.W. et al. Gut 1996; 38:806-811. GI Motility Education Centres Literature Summaries 2 (1).

Preiksaitis, H.G., and N.E. Diamant. 1997. Regional differences in cholinergic activity of muscle fibers from the human gastroesophageal junction. American Journal Physiology (Gastrointestinal and Liver Physiolgy) 35: G1321-G1327.

 

RALPH, E.D.

Ralph, E.D., and Z. Hussain. 1996. Chronic meningitis caused by Candida albicans in a liver transplant recipient: Usefulness of the polymerase chain reaction for diagnosis and for monitoring treatment. Clinical Infectious Diseases 23: 191-192.

 

RODGER, N.W.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 45: 1289-1298.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1997. Clustering of long-term complications in families with diabetes in The Diabetes Control and Complications Trial. Diabetes 46: 1829-1839.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1997. Hypoglycaemia in the DCCT. Diabetes 46: 271-286.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. Lifetime benefits and costs of intensive therapy as practised in the Diabetes Control and Complication Trial. JAMA 276: 1409-1415.

Diabetes Control and Complications Trial (DCCT) Research Group, J. Dupre, I. Hramiak, and N.W. Rodger. 1996. Pregnancy outcomes in the DCCT. American Journal of Obstetrics and Gynecology 174: 1343-1353.

Rodger, N.W. 1997. Case studies in endocrinology, diabetes and metabolism. Annals of the Royal College of Physicians and Surgeons of Canada 30: 180.

Rodger, N.W. 1996. Diagnosis and management of type II diabetes. The Canadian Journal of Diagnosis 13: 75-89.

 

SAWYEZ, C.G.

Huff, M.W., D.B. Miller, B.M. Wolfe, P.W. Connelly, and C.G. Sawyez. 1997. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. Journal of Lipid Research 38: 1318-1333.

 

SHARPE, M.D.

Sharpe, M.D. 1996. Anaesthesia and the transplanted patient Refresher Course Outline. Canadian Journal of Anaesthesia : R89-R93.

Sharpe, M.D., and A.B. Cooper. 1996. Bacterial meningitis and cauda equina syndrome following epidural steroid injections. Canadian Journal of Anaesthesia 43: 471-474.

Sharpe, M.D., and A.W. Gelb. 1997. Anesthetic management of the patient with a transplanted organ. Neuroanesthesia. J.C. Johnson, R.J. Sperry, and T.H. Stanley. Dordrecht: Kluwer Academic Publishers. 371-379.

Sharpe, M.D., R. Zhong, J. Tucker, D. Grant, W. Wall, B. Garcia, S. Asfar, Z. Zhang, A. Gelb, and C.R. Stiller. 1996. The long term survival and functional tolerance of baboon-to-monkey kidney and liver xenografts: A preliminary report. Transplantation Proceedings 28: 762.

Sharpe, M.D., and W. Zimmerman. 1996. Parkinson's Disease. Essence of Anesthesia Practice. M.F. Roizen, and L.A. Fleisher. Philadelphia: WB Saunders. 242.

 

SIBBALD, W.J.

Cooper, A.B., G.S. Doig, and W.J. Sibbald. 1996. Pulmonary artery catheters in the critically ill. Critical Care Clinics: Monitoring Cardiac Function and Tissue Perfusion 12 (4): 777-794.

Farquhar, I., C.M. Martin, C. Lam, R. Potter, C. Ellis, and W.J. Sibbald. 1996. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. Journal of Surgical Research 1: 190-196.

Fitzgerald, R.D., C.M. Martin, G.E. Dietz, G.S. Doig, R.F. Potter, and W.J. Sibbald. 1997. Transfusing RBCs stored in CPDA-1 for 28 days fails to improve tissue oxygenation in rats. Critical Care Medicine 25: 726-732.

Keenan, S.P., K.D. Busche, L.M. Chen, L. McCarthy, K.J. Inman, and W.J. Sibbald. 1997. A retrospective review of a large cohort of patients undergoing the process of withholding or withdrawal of life support: The real picture? Critical Care Medicine 25: 1324-1331.

Keenan, S.P., G.S. Doig, C.M. Martin, K.J. Inman, and W.J. Sibbald. 1997. Assessing the efficiency of the admission process to a critical care unit: Does the literature allow the use of benchmarking? Intensive Care Medicine 23: 574-580.

Keenan, S.P., P. Kernerman, D. Cook, C.M. Martin, D.G. McCormack, and W.J. Sibbald. 1997. Effect of noninvasive positive pressure ventilation on mortality in patients with acute respiratory failure: A meta-analysis. Critical Care Medicine 25: 1685-1692.

Keenan, S.P., C.M. Martin, D.J. Cook, and W.J. Sibbald. 1997. An evidence-based learning and teaching tool: The critically appraised topic (CAT). Critical Care (Introductory Issue): 19-22.

Leasa, D.J., and W.J. Sibbald. 1997. The rationing of critical care services in Canada. Current Opinion in Critical Care : 317-321.

Martin, C.M., and W.J. Sibbald. 1996. Oxygen delivery in critically ill patients. Current Opinion in Critical Care 2: 386-390.

Ng, S.W., R. Esmail, W.J. Sibbald, and G.S. Doig. 1996. Potential savings involved in the purchase of low-cost, high-volume medical commodities as established from a community hospital survey. Healthcare Management Forum 9: 24-30.

Piper, R., D. Cook, R. Bone, and W.J. Sibbald. 1996. Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Critical Care Medicine 24: 2059-2070.

Piper, R., M. Pitt-Hyde, F. Li, W.J. Sibbald, and R. Potter. 1996. Microcirculatory changes in rat skeletal muscle in sepsis. American Journal of Respiratory and Critical Care Medicine 154: 931-937.

Sielenkemper, A.W., I.H. Chin-Yee, C.M. Martin, and W.J. Sibbald. 1996. Diapirin cross-linked hemoglobin improves system oxygen uptake in oxygen supply-dependent septic rats. American Journal of Respiratory and Critical Care Medicine 154 (3).

Yu, P., D.R. Boughner, W.J. Sibbald, J. Keys, J. Dunmore, and C.M. Martin. 1997. Myocardial collagen changes and edema in rats with hyperdynamic sepsis. Critical Care Medicine 25: 657-662.

 

SPENCE, J.D.

Hachinski, V.C., C. Graffagnino, M. Beaudry, G. Bernier, C. Buck, A. Donner, J.D. Spence, G.S. Doig, and B.M. Wolfe. 1996. Hyperlipidemia is a significant risk factor for stroke. Archives of Neurology 53: 303-308.

Rau, S.E., J.R. Bend, J.M.O. Arnold, L.T. Tran, J.D. Spence, and D.G. Bailey. 1997. Grapefruit juice - terfenadine single-dose interaction: Magnitude, mechanism and relevance. Clinical Pharmacology and Therapeutics 61 (4): 401-409.

 

STILLER, C.R.

Atkison, P.R., P. Zucker, I. Hramiak, T.L. Paul, J. Dupre, M.T. Behme, D.S.W. Scharp, P.E. Lacy, B.J. Olack, and C.R. Stiller. 1996. Continued insulin dependence despite normal range insulin sensitivity and insuline connecting peptide levels in a kidney/islet transplant patient. Diabetes Care 19 (3): 236-240.

Dupre, J., J.L. Mahon, and C.R. Stiller. 1997. Prevention of development of progression of B-cell damage in insulin-dependent diabetes mellitus. Textbook of Diabetes, Volume 82.1. J. Pickup, and G. Williams. Oxford: Blackwell Scientific Publications. 82.11.

Keown, P.A., D. Landsberg, P. Halloran, A. Shoker, D. Rush, J. Jeffrey, D. Russell, C.R. Stiller, N. Muirhead, E. Cole, L. Paul, R. Zaltzman, P. Loertscher, Daloze. P., R. Dandevino, A. Boucher, P. Handa, J. Lauren, P. Belitsky, P. Parkfrey, and The Canadian Neural Transplantation Study Group. 1996. A randomized, prospective multicentre pharmacoepidemiologic study of cyclosporine microemulsion in stable renal grafts recipients. Transplantation 62: 1744-1752.

Keown, P.A., D. Landsberg, P. Halloran, A. Shoker, D. Rush, J. Jeffrey, D. Russell, C.R. Stiller, N. Muirhead, E. Cole, L. Paul, R. Zaltzman, P. Loertscher, Daloze. P., R. Dandevino, A. Boucher, P. Handa, J. Lauren, P. Belitsky, P. Parkfrey, and The Canadian Neural Renal Transplantation Group. 1997. Reduced pharmokinetic variability in renal graft recipients treated with cyclosporine microemulsion. Results of a randomized, prospective pharmacoepidemiologic comparison. Transplantation.

Keown, P.A., D. Landsberg, P. Halloran, A. Shoker, D. Rush, J. Jeffrey, D. Russell, C.R. Stiller, N. Muirhead, E. Cole, L. Paul, R. Zaltzman, P. Loertscher, Daloze. P., R. Dandevino, A. Boucher, P. Handa, J. Lauren, P. Belitsky, P. Parkfrey, and The Canadian Neural Renal Transplantation Group. 1997. Safety and tolerability of cyclosporine and clyclosporine microemulsion during 18 months of follow-up in stabel renal transplant recipients. Transplantation.

Lazarovits, A.I., S. Poppema, Z. Zhang, M. Khandaker, C.E. Le Feuvre, S.K. Singhal, B.M. Garcia, N. Ogasa, A.M. Jevnikar, M.J. White, G. Singh, C.R. Stiller, and R.Z. Zhong. 1996. Therapy for mouse renal allograft rejection by monoclonal antibody to CD45RB. Transplantation Proceedings 28: 3208-3209.

Ma, S.-W., D.-L. Zhao, Z.-Q. Yin, R. Mukherjee, B. Singh, H.-Y. Qin, C.R. Stiller, and A.M. Jevnikar. 1997. Transgenic plants expressing autoantigens to induce oral tolerance. Nature Medicine 3: 793-796.

Sharpe, M.D., R. Zhong, J. Tucker, D. Grant, W. Wall, B. Garcia, S. Asfar, Z. Zhang, A. Gelb, and C.R. Stiller. 1996. The long term survival and functional tolerance of baboon-to-monkey kidney and liver xenografts: A preliminary report. Transplantation Proceedings 28: 762.

Zhang, Z., L. Zhu, D. Quan, B. Garcia, N. Ozcay, J. Duff, C.R. Stiller, A.I. Lazarovits, D. Grant, and R. Zhong. 1996. The pattern of liver, kidney, heart and intestine allograft rejection in different mouse strain combinations. Transplantation 62: 1267-1272.

 

TOOGOOD, J.H.

Brenner, A.M., J.H. Toogood, and A.B. Hodsman. 1997. Steroid-induced osteoporosis in the asthmatic patient: diagnosis and management. Annals of Allergy, Asthma and Immunology Invited review.

Toogood, J.H. 1996. Effects of Inhaled Steroid Therapy for Asthma on Skeletal Metabolism. Inhaled Glucocorticoids in Asthma - Mechanisms and Clinical Actions. R.P. Schleimer, W.W. Busse, and P.M. O'Byrne. New York, NY: Marcel Dekker Inc. 607-626.

Toogood, J.H. 1997. Inhaled Steroids. Asthma, Volume 2. P.J. Barnes, M.M. Grunstein, A.R. Leff, and A.J. Woolcock. Philadelphia, NY: Lippincott-Raven Press. 1597-1617.

Toogood, J.H. 1996. Inhaled Steroids and Bone Density. Canadian Journal of Allergy and Clinical Immunology 1 (4): 124. Guest Editorial.

Toogood, J.H., P. Andreou, and J. Baskerville. 1996. A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations. Journal of Allergy and Clinical Immunology 98: 555-562.

Toogood, J.H., N.A.M. Paterson, and F.A. White. 1997. Corticosteroids and Anti-Metabolites. Allergy. A.P. Kaplan. Philadelphia, PA: W.B.Saunders Co. 706-725.

Toogood, J.H., and F.A. White. 1996. Corticosteroids: Mechanisms of Action and Treatment of Allergic Disease. Immunopharmacology of Allergic Diseases. R.G. Townley, and D.K. Agrawal. New York: Marcel Dekker. 675-706.

Toogood, J.H., F.A. White, J.C. Baskerville, L.J. Fraher, and B. Jennings. 1997. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbohaler dry powder inhaler. Journal of Allergy and Clinical Immunology 99: 186-193.

Van Schoor, J., J.H. Toogood, and R.A. Pauwels. 1997. Differential effects of inhaled budesonide and oral prednisolone on serum immunoglobulin G and its subclasses in healthy adult volunteers. Clinical and Experimental Allergy 27: 192-195.

 

VALBERG, L.S.

Valberg, L.S., and D.A. Lloyd. 1997. Multimedia program for student and resident education. (Videotape).

 

VELDHUIZEN, R.

Borron, P., R. Veldhuizen, L.J. Fraher, F. Possmayer, A.N. Caveney, J.F. Lewis, K. Inchley, and R.G. McFadden. 1996. Bovine surfactant associated protein-A inhibits phytohaemagglutonin stimulated human lymphocytes, proliferation and IL-2 production. American Journal of Respiratory Cell and Molecular Biology 15: 115-121.

Ito, Y., R. Veldhuizen, L.J. Yao, L. McCaig, A. Bartlett, and J.F. Lewis. 1997. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. American Journal of Respiratory and Critical Care Medicine 155 (2): 493-499.

Novick, R.J., A. Gilpin, K. Gehman, I. Ali, R. Veldhuizen, J.C. Duplan, L.M. Denning, F. Possmayer, D. Bjarneson, and J.F. Lewis. 1996. Mitigation of injury in canine lung grafts by exogenous surfactant therapy. Journal of Thoracic and Cardiovascular Surgery 113 (2): 342-353.

 

WEINGERT, M.E

The Digitalis Investigation Group, J.M.O. Arnold, and M.E. Weingert. 1997. The effect of digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine 336 (8): 525-533.

Hurwitz, G.A., A.C. MacDonald, M.E. Weingert, R.C. Hessian, K.J.C. Finnie, G. St. Clement, and J.E. Powe. 1996. Myocardial uptake and washout kinetics of T1-201 with the VEX (vasodilator plus exercise) test: Contribution of stress mode components and coronary stenosis severity. Canadian Journal of Cardiology 12 (7): 648-656.

 

WELLS, J.

Wells, J., L. Diachun, C. Cook, and C.D. Brymer. 1996. Internal Medicine Residents' Attitudes Toward and Knowledge of Geriatric Medicine. Annals of the Royal College of Physicians and Surgeons of Canada 29 (8): 468-472.

 

WISENBERG, G.

Campbell, C.M., G. Wisenberg, R.T. Thompson, and J. Sykes. 1997. Controlled reperfusion after myocardial ischemia in a canine model monitored by two dimensional phosphorous 31 chemical shift spectroscopic imaging. American Heart Journal 133 (5): 508-516.

Farrall, A.J., R.T. Thompson, G. Wisenberg, C.M. Campbell, and D.J. Drost. 1997. Myocardial infarcation in a canine model monitored by two dimensional üûP chemical shift spectroscopic imaging. Magnetic Resonance In Medicine 38: 577-584.

Pereira, R.S., F.S. Prato, G. Wisenberg, and J. Sykes. 1996. The determination of myocardial viability using Gd-DPTA in a canine model of acute myocardial ischemia and reperfusion. Magnetic Resonance In Medicine 36: 684-693.

 

WOLFE, B.M.

Hachinski, V.C., C. Graffagnino, M. Beaudry, G. Bernier, C. Buck, A. Donner, J.D. Spence, G.S. Doig, and B.M. Wolfe. 1996. Hyperlipidemia is a significant risk factor for stroke. Archives of Neurology 53: 303-308.

Huff, M.W., D.B. Miller, B.M. Wolfe, P.W. Connelly, and C.G. Sawyez. 1997. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. Journal of Lipid Research 38: 1318-1333.

Whitman, S.C., D.B. Miller, B.M. Wolfe, R.A. Hegele, and M.W. Huff. 1997. Uptake of type III hypertriglyceridemic VLDL by macophages is enhanced by oxidation, especially after remnant formation. Arteriosclerosis, Thrombosis, and Vascular Biology 17: 1707-1715.

Wolfe, B.M. 1996. 'Ask the Experts': For optimal treatment of coronary heart disease, should we put our patients on anti-ipidemic agents to prevent recurrences and possibl induce regression? Is there hard data for this? If so, what class of agents is recommended? Canadian Journal of Diagnosis 13: 25-26.

 

XIAO, Q.

Wang, Y.F., Y.K. Mao, Q. Xiao, E.E. Daniel, K.R. Borkowski, and T.J. McDonald. 1997. The distribution of NPY-containing nerves and the catecholamine contents of canine enteric nerve plexuses. Peptides 18: 221-234.

 

YAO, L. -. J.

Ito, Y., R. Veldhuizen, L.J. Yao, L. McCaig, A. Bartlett, and J.F. Lewis. 1997. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. American Journal of Respiratory and Critical Care Medicine 155 (2): 493-499.

 

YEE, R.

Bardy, G.H., F.E. Marchlinski, S.J. Worley, R.M. Luceri, R. Yee, B.D. Halperin, C.L. Fellows, T.S. Ahern, D.A. Chilson, D.L. Packer, D.J. Wilber, T.A. Mattioni, R. Reddy, R.A. Kronmal, and R. Lazzara. 1996. Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Circulation 94 (10): 2507-2514.

Guiradon, G.M., C.M. Guiraudon, G.J. Klein, and R. Yee. 1997. Atrial fibrillation functional anatomy: Surgical Rationales. Ten Years of Radiofrequency Catheter Ablation. C. Moro, and J. Farre. Armonk, NY: Futura Publishing Co. Inc.

Guiraudon, G.M., C.M. Guiraudon, G.J. Klein, and R. Yee. 1997. Atrial fibrillation in the future: The surgeon's perspective. Nonpharmacological Management of Atrial Fibrillation, Volume 17. F.D. Murgatroyd, and A.J. Camm. Armonk, NY: Futura Publishing Co. Inc. 215-237.

Guiraudon, G.M., G.J. Klein, C.M. Guiraudon, and R. Yee. 1996. Surgical treatment of atrial fibrillation: What's new? Long-term follow-up. Heart Web 2 (1): 9611002.

Guiraudon, G.M., G.J. Klein, C. Guiraudon, and R. Yee. 1996. Intervenciones quirurgicas para el tratamiento de la fibrilacion auricular=Surgical interventions for atrial fibrillation. Ed Latina Electrocard 2 (2): 13-24.

Guiraudon, G.M., G.J. Klein, and R. Yee. 1997. Approches chirurgicales de la fibrillation auriculaire. La fibrillation auriculaire. J.-V. Le Heuzey. Paris, France: Editions Louis Pariente. 377-396.

Guiraudon, G.M., G.J. Klein, and R. Yee. 1997. Surgical techniques in supraventricular tachycardias. Interventional Electrophysiology, Volume 18. I. Singer. Baltimore, MD: Williams and Wilkins. 565-593.

Guiraudon, G., C. Guiraudon, L.H. Chow, R. Yee, W.J. Kostuk, and G.J. Klein. 1996. Latissimus dorsi cardiomyoplasty combined with ICD implant. Les journees de la Pitie: Transplantation cardiaque et pulmonaire, cardiomyoplastie, assistance circulatoire. C. Cabrol, I. Gandjbakhch, and A. Pavie. Montpellier, France: R & J Editions Medicales and Sauramps. 167-170.

Krahn, A.D., G.J. Klein, G. Guiraudon, and R. Yee. 1997. Ablation of posteroseptal accessory pathways (Chapter 8). Interventional Electrophysiology. I. Singer. Baltimore, MD: Williams and Wilkins. 231-252.

Krahn, A.D., G.J. Klein, and R. Yee. 1997. Recurrent Sycope: Experience with an Implantable Loop Recorder. Cardiology Clinics 15 (2): 313-326.

Krahn, A.D., G.J. Klein, and R. Yee. 1996. Recurrent unexplained syncope: Diagnostic and therapeutic approach. Canadian Journal of Cardiology 12 (10): 989-994.

Krahn, A.D., G.J. Klein, R. Yee, and The Mansfield Polaris Investigators. 1997. Time dependent change in fast pathway refractoriness after slow pathway ablation in patients with atrioventricular node reentrant tachycardia. Canadian Journal of Cardiology 13 (6): 583-588.

Krahn, A.D., G.J. Klein, R. Yee, and C. Norris. 1997. Maturation of the sensed electrogram amplitude over time in a new subcutaneous implantable loop recorder. PACE 20: 1686-1690.

Morillo C.A., G.J. Klein, R. Yee, and G.M. Guiraudon. 1997. The Wolff-Parkinson-White syndrome. Clinical Approaches to Tachyarrhythmias. A.J. Camm. Armonk, NY: Futura Publishing Company, Inc. 6.

Murkin, J.M., D.L. Baird, J.S. Martzke, and R. Yee. 1997. Cognitive dysfunction after ventricular fibrillation during implanable cardiovertor/defibrillator procedures is related to duration of the reperfusion interval. Anesthesia and Analgesia 84: 1186-1192.

Rosenbaum, M., G.J. Klein, A.D. Krahn, M. Basta, C. Le Feuvre, and R. Yee. 1997. Utility of full electrophysiological study before accessory pathway ablation in Wolff-Parkinson-White syndrome. Canadian Journal of Cardiology 13 (4): 359-362.

 

YIN, Z-Q.

Ma, S.-W., D.-L. Zhao, Z.-Q. Yin, R. Mukherjee, B. Singh, H.-Y. Qin, C.R. Stiller, and A.M. Jevnikar. 1997. Transgenic plants expressing autoantigens to induce oral tolerance. Nature Medicine 3: 793-796.

 

ZARNKE, K.B.

Zarnke, K.B. 1996. Evidence-Based Medicine: Pharmacological treatment of hypertension in the elderly. Medicine North America 19: 12-18.

Zarnke, K.B. 1997. Treatment of hypertension: A primer in pharmoeconomics. Hypertension Canada (April): 1-7.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. Patient directed hypertention management. American Journal of Hypertension 10: 58-67.

Zarnke, K.B., B.G. Feagan, J.L. Mahon, and R.D. Feldman. 1997. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. American Journal of Hypertension 10: 58-67.